<SEC-DOCUMENT>0001104659-24-086030.txt : 20240806
<SEC-HEADER>0001104659-24-086030.hdr.sgml : 20240806
<ACCEPTANCE-DATETIME>20240806060418
ACCESSION NUMBER:		0001104659-24-086030
CONFORMED SUBMISSION TYPE:	DFRN14A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20240806
DATE AS OF CHANGE:		20240806

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MASIMO CORP
		CENTRAL INDEX KEY:			0000937556
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				330368882
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1228

	FILING VALUES:
		FORM TYPE:		DFRN14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33642
		FILM NUMBER:		241176898

	BUSINESS ADDRESS:	
		STREET 1:		52 DISCOVERY
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92618
		BUSINESS PHONE:		949-297-7000

	MAIL ADDRESS:	
		STREET 1:		52 DISCOVERY
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92618

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Politan Capital Management LP
		CENTRAL INDEX KEY:			0001885245
		ORGANIZATION NAME:           	
		IRS NUMBER:				871666292
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DFRN14A

	BUSINESS ADDRESS:	
		STREET 1:		106 WEST 56TH STREET
		STREET 2:		10TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
		BUSINESS PHONE:		(212) 756-2000

	MAIL ADDRESS:	
		STREET 1:		106 WEST 56TH STREET
		STREET 2:		10TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
</SEC-HEADER>
<DOCUMENT>
<TYPE>DFRN14A
<SEQUENCE>1
<FILENAME>tm2420840d1_dfrn14a.htm
<DESCRIPTION>DFRN14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SCHEDULE
14A</B></FONT><B><BR>
</B>(Rule&nbsp;14a-101)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">INFORMATION REQUIRED IN PROXY STATEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SCHEDULE 14A INFORMATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Proxy Statement Pursuant to Section&nbsp;14(a)&nbsp;of
the Securities Exchange Act of 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Amendment No.&nbsp;1)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Filed
by the Registrant </FONT><FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Filed
by a Party other than the Registrant </FONT><FONT STYLE="font-family: Wingdings">&#120;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#168;</FONT></TD><TD STYLE="text-align: justify">Preliminary
                                            Proxy Statement</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Confidential,
                                            for Use of the Commission Only (as permitted by Rule&nbsp;14a-6(e)(2))</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#120;</FONT></TD><TD STYLE="text-align: justify">Definitive
                                            Proxy Statement</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Definitive
                                            Additional Materials</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Soliciting
                                            Material Under &sect;&nbsp;240.14a-12</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt">Masimo
    Corporation</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of Registrant as Specified In Its Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">POLITAN
    CAPITAL MANAGEMENT LP<BR>
    POLITAN CAPITAL MANAGEMENT GP LLC<BR>
    POLITAN CAPITAL PARTNERS GP LLC<BR>
    POLITAN CAPITAL NY LLC<BR>
    POLITAN INTERMEDIATE LTD.<BR>
    POLITAN CAPITAL PARTNERS MASTER FUND LP<BR>
    POLITAN CAPITAL PARTNERS LP<BR>
    POLITAN CAPITAL OFFSHORE PARTNERS LP<BR>
    QUENTIN KOFFEY<BR>
    MATTHEW HALL<BR>
    AARON KAPITO<BR>
    WILLIAM JELLISON<BR>
    DARLENE SOLOMON</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of Persons(s)&nbsp;Filing Proxy Statement,
if other than the Registrant)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Payment of Filing Fee (Check all boxes that apply):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#120;</FONT></TD><TD STYLE="text-align: justify">No
                                            fee required</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Fee
                                            paid previously with preliminary materials</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Fee
                                            computed on table in exhibit required by Item 25(b)&nbsp;per Exchange Act Rules&nbsp;14a-6(i)(1)&nbsp;and
                                            0-11</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Explanatory Note</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This amended and restated proxy statement (the
 &ldquo;<U>Proxy Statement</U>&rdquo;) amends, supersedes and replaces entirely the definitive proxy statement filed with the Securities
and Exchange Commission (the &ldquo;<U>SEC</U>&rdquo;) on June&nbsp;21, 2024 (the &ldquo;<U>Original Proxy Statement</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Participants (as defined in this Proxy Statement)
made the Original Proxy Statement available to the stockholders (the &ldquo;<U>Stockholders</U>&rdquo;) of Masimo Corporation (&ldquo;<U>Masimo</U>&rdquo;
or the &ldquo;<U>Company</U>&rdquo;) in connection with the Participants&rsquo; solicitation of proxies at the 2024 annual meeting of
Stockholders of the Company (including any and all adjournments, postponements, continuations or reschedulings thereof, or any other
meeting of Stockholders of the Company held in lieu thereof, the &ldquo;<U>2024 Annual Meeting</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As described in greater detail in this Proxy
Statement, the Company announced on July&nbsp;16, 2024 that it had set a new record date of August&nbsp;12, 2024 for the determination
of Stockholders of the Company entitled to receive notice of, and vote at, the 2024 Annual Meeting (which date the Company had previously
set as June&nbsp;13, 2024). The Company also announced that it had postponed the 2024 Annual Meeting to September&nbsp;19, 2024 from
July&nbsp;25, 2024. As of the date of this Proxy Statement, the 2024 Annual Meeting is scheduled to be held at 2:00 p.m.&nbsp;Pacific
Daylight Time on September&nbsp;19, 2024, at the Masimo Corporation Headquarters located at 52 Discovery,&nbsp;Irvine, California 92618.
Furthermore, the Company announced that: &ldquo;Any votes previously submitted by Masimo stockholders in connection with the 2024 Annual
Meeting will not be counted and previous proxies submitted will be disregarded, and therefore, all stockholders will need to resubmit
their votes, even if they have previously voted.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing events were announced after the
Original Proxy Statement and corresponding original proxy card and original voting instruction form were filed with the SEC and sent
to the Company&rsquo;s Stockholders and after the Company&rsquo;s Stockholders had the ability to vote using such original proxy card
or original voting instruction form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
updated Proxy Statement and the enclosed <B>updated WHITE universal proxy card and voting instruction form</B> are first being
mailed to the Company&rsquo;s Stockholders on or about August 19</FONT>, 2024. Stockholders should read the Proxy Statement in its
entirety.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>If you have previously voted on the WHITE universal
proxy card or voting instruction form for the annual meeting previously scheduled for July&nbsp;25, 2024, your vote is no longer valid.
To enable your votes to be validly counted for the 2024 Annual Meeting, you must resubmit your vote on the updated WHITE universal proxy
card or voting instruction form attached to this Proxy Statement for the 2024 Annual Meeting now scheduled to be held on September&nbsp;19,
2024.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2024 ANNUAL MEETING OF STOCKHOLDERS<BR>
OF<BR>
MASIMO CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROXY STATEMENT<BR>
OF<BR>
POLITAN CAPITAL MANAGEMENT LP<BR>
POLITAN CAPITAL MANAGEMENT GP LLC<BR>
POLITAN CAPITAL PARTNERS GP LLC<BR>
POLITAN CAPITAL NY LLC<BR>
POLITAN INTERMEDIATE LTD.<BR>
POLITAN CAPITAL PARTNERS MASTER FUND LP<BR>
POLITAN CAPITAL PARTNERS LP<BR>
POLITAN CAPITAL OFFSHORE PARTNERS LP<BR>
QUENTIN KOFFEY<BR>
MATTHEW HALL<BR>
AARON KAPITO<BR>
WILLIAM JELLISON<BR>
DARLENE SOLOMON</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PLEASE SIGN, DATE AND MAIL THE ENCLOSED<BR>
UPDATED WHITE UNIVERSAL PROXY CARD OR VOTING INSTRUCTION FORM&nbsp;TODAY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">This amended and restated proxy
statement (this &ldquo;<U>Proxy Statement</U>&rdquo;) and accompanying <B>updated WHITE proxy card and voting instruction form </B>are
being furnished to stockholders of Masimo Corporation, a Delaware corporation (&ldquo;<U>Masimo</U>&rdquo; or the &ldquo;<U>Company</U>&rdquo;),
by Politan Capital Management LP, a Delaware limited partnership (&ldquo;<U>Politan</U>&rdquo;), Politan Capital Management GP LLC, a
Delaware limited liability company (&ldquo;<U>Politan Management</U>&rdquo;), Politan Capital Partners GP LLC, a Delaware limited liability
company (&ldquo;<U>Politan GP</U>&rdquo;), Politan Capital NY LLC, a New York limited liability company (the &ldquo;<U>Record Stockholder</U>&rdquo;),
Politan Intermediate Ltd., an exempted company organized under the laws of the Cayman Islands (&ldquo;<U>Politan Ltd.</U>&rdquo;), Politan
Capital Partners Master Fund LP, an exempted limited partnership organized under the laws of the Cayman Islands (&ldquo;<U>Politan Master
Fund</U>&rdquo;), Politan Capital Partners LP, a Delaware limited partnership (&ldquo;<U>Politan LP</U>&rdquo;), and Politan Capital
Offshore Partners LP, an exempted company organized under the laws of the Cayman Islands (&ldquo;<U>Politan Offshore</U>&rdquo; and together
with Politan LP and Politan Master Fund, collectively, the &ldquo;<U>Politan Funds</U>&rdquo;), Quentin Koffey, Matthew Hall, and Aaron
Kapito (all of the foregoing Politan entities or individuals, collectively, the &ldquo;<U>Politan Parties</U>&rdquo; or &ldquo;<U>we</U>,&rdquo;
 &ldquo;<U>our</U>&rdquo; or &ldquo;<U>us</U>&rdquo;), William Jellison and Darlene Solomon (such individuals collectively with the Politan
Parties, the &ldquo;<U>Participants</U>&rdquo;) in connection with the solicitation of proxies from the holders (the &ldquo;<U>Stockholders</U>&rdquo;)
of common stock, $0.001 par value, of the Company (the &ldquo;<U>Common Stock</U>&rdquo;) at the 2024 annual meeting of Stockholders
of the Company (including any and all adjournments, postponements, continuations or reschedulings thereof, or any other meeting of Stockholders
held in lieu thereof, the &ldquo;<U>2024 Annual Meeting</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
Proxy Statement and the enclosed <B>updated WHITE universal proxy card or voting instruction form</B> are first being mailed to Stockholders
on or about August 19</FONT>, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">As a significant, long-term
Stockholder of Masimo, we are committed to maximizing the value of the Company for all Stockholders. To this end, we nominated a full
slate of two independent director candidates to the Board of Directors of the Company (the &ldquo;<U>Board</U>&rdquo;) at the 2023 annual
meeting of Stockholders (the &ldquo;<U>2023 Annual Meeting</U>&rdquo;): Michelle Brennan and Quentin Koffey (the &ldquo;<U>2023 Newly-Elected
Directors</U>&rdquo;). Stockholders overwhelmingly elected the 2023 Newly-Elected Directors at the 2023 Annual Meeting. However, in spite
of this resounding call for change, we believe that the Board and management team undermined attempts to improve the Company&rsquo;s
broken corporate governance&mdash;resulting in financial metrics, total shareholder return, and material risks to the Company only worsening
(and which we describe in greater detail in the &ldquo;<FONT STYLE="text-transform: uppercase">Background of the Solicitation</FONT>&rdquo;
discussion in this Proxy Statement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">It has become clear to Politan
that more comprehensive action &mdash; including additional stockholder-driven change in the boardroom &mdash; is required to protect
Stockholders from the legacy issues that plague the Company and to reposition the Company so that it can realize its full potential.
Accordingly, we are nominating two high-qualified, independent director candidates: William Jellison and Darlene Solomon (each, a &ldquo;<U>Politan
Nominee</U>&rdquo; and, together, the &ldquo;<U>Politan Nominees</U>&rdquo;), each of whom has ideal operational, industry and financial
expertise, and is committed to bringing fully objective and openminded perspectives to the Board. We believe that, together with the
2023 Newly-Elected Directors, the Politan Nominees will be fierce advocates for Stockholders and for best in class corporate governance
practices, and will facilitate a renewed focus on value creation in the Masimo boardroom.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">We are seeking your support
at the 2024 Annual Meeting scheduled to be held at the Masimo Corporation Headquarters located at 52 Discovery,&nbsp;Irvine, California
92618 on September&nbsp;19, 2024, at 2:00 p.m., Pacific Daylight Time, in connection with the following items of business:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify">Election of our two director nominees, William
                                            Jellison and Darlene Solomon, to the Board as Class&nbsp;II directors to serve until the
                                            2025 annual meeting of Stockholders (the &ldquo;<U>2025 Annual Meeting</U>&rdquo;) and until
                                            their respective successors are duly elected and qualified;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify">Ratification of the selection of Grant Thornton
                                            LLP as the Company&rsquo;s independent registered public accounting firm for the fiscal year
                                            ending December&nbsp;28, 2024 (&ldquo;<U>Ratification of Auditors</U>&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify">The advisory vote to approve the compensation
                                            of the Company&rsquo;s named executive officers; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify">To approve the repeal of each provision of,
                                            or amendment to, the Company&rsquo;s Fifth Amended and Restated Bylaws (as amended, supplemented
                                            or modified from time to time, the &ldquo;<U>Bylaws</U>&rdquo;) that the Board adopted without
                                            the approval of Stockholders subsequent to April&nbsp;20, 2023, which is the date of the
                                            most recent publicly available amendment to the Bylaws, and up to and including the date
                                            of the 2024 Annual Meeting (the &ldquo;<U>Bylaw Proposal</U>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Through this Proxy Statement
and enclosed <B>updated WHITE universal proxy card or voting instruction form</B>, we are soliciting proxies to elect the two Politan
Nominees to become Class&nbsp;II directors. The Politan Parties and Masimo will each be using a universal proxy card for voting on the
election of directors at the 2024 Annual Meeting, which will include the names of all nominees for election to the Board. Stockholders
will have the ability to vote for up to two nominees on the Politan Parties&rsquo; enclosed <B>updated WHITE universal proxy card or
voting instruction form</B>. There is no need to use the Company&rsquo;s gold proxy card or voting instruction form, regardless of how
you wish to vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Assuming the Politan Nominees
receive sufficient votes to be elected to the Board, your vote to elect the Politan Nominees will have the legal effect of replacing
two incumbent directors of the Company on the Board. If elected, the Politan Nominees, subject to their fiduciary duties as directors,
will seek to work with the other members of the Board to maximize Stockholder value. Together with the 2023 Newly-Elected Directors,
the Politan Nominees will constitute a majority on the Board. There is no assurance that the Company&rsquo;s other directors will serve
as directors if one or both of the Politan Nominees are elected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">You should refer to the proxy
statement filed by the Company in connection with the 2024 Annual Meeting (as amended, the &ldquo;<U>Company Proxy Statement</U>&rdquo;)
for the 2024 Annual Meeting, which may be accessed without cost on the Securities and Exchange Commission&rsquo;s website at <U>www.sec.gov</U>,
for the names, background, qualifications and other information concerning the Company&rsquo;s nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Stockholders are permitted
to vote for less than two nominees or for any combination (up to two total) of the Politan Nominees and the Company&rsquo;s nominees
on the <B>updated WHITE universal proxy card or voting instruction form</B>. The Politan Parties urge Stockholders to use our <B>updated
WHITE universal proxy card or voting instruction form</B> to vote <B>&ldquo;FOR&rdquo;</B> both of the Politan Nominees and vote to &ldquo;<B>WITHHOLD</B>&rdquo;
on the Company&rsquo;s nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>IMPORTANTLY,&nbsp;IF YOU
MARK MORE THAN TWO &ldquo;FOR&rdquo; BOXES WITH RESPECT TO THE ELECTION OF DIRECTORS, ALL OF YOUR VOTES FOR THE ELECTION OF DIRECTORS
WILL BE DEEMED INVALID.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Company has set the close
of business on August&nbsp;12, 2024 as the record date for determining Stockholders entitled to notice of, and to vote at, the 2024 Annual
Meeting (the &ldquo;<U>Record Date</U>&rdquo;). Stockholders of record at the close of business on the Record Date will be entitled to
vote at the 2024 Annual Meeting. Each outstanding share of Common Stock is entitled to one vote on each matter to be voted on at the
2024 Annual Meeting. According to the Company Proxy Statement, at the close of business on the Record Date, there were 53,182,247 shares
of Common Stock outstanding and entitled to vote and no shares of preferred stock outstanding or entitled to vote. The mailing address
of the principal executive offices of the Company is 52 Discovery,&nbsp;Irvine, California 92618.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">As of the date hereof, the
members of the Politan Parties in this solicitation collectively own an aggregate of 4,713,518 shares of Common Stock (the &ldquo;<U>Politan
Group Shares</U>&rdquo;). Mr.&nbsp;Koffey may be deemed to own an aggregate of 4,714,746 shares of Common Stock, which includes 1,228
shares of Common Stock that vested on June&nbsp;26, 2024 from the restricted stock units (&ldquo;<U>RSUs</U>&rdquo;) granted to Mr.&nbsp;Koffey
on June&nbsp;26, 2023 by virtue of his position as a director of the Company (such shares, the &ldquo;<U>Koffey Shares</U>&rdquo; and,
together with the Politan Group Shares, the &ldquo;<U>Politan Shares</U>&rdquo;). The applicable Participants intend to vote the Politan
Shares <B>&ldquo;FOR&rdquo;</B> the election of the Politan Nominees, <B>&ldquo;FOR&rdquo; </B>the ratification of Grant Thornton LLP
as the Company&rsquo;s independent registered public accounting firm for the 2024 fiscal year, <B>&ldquo;AGAINST&rdquo;</B> the approval
of named executive officer compensation and <B>&ldquo;FOR&rdquo;</B> the approval of the Bylaw Proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">We urge you to carefully consider
the information contained in this Proxy Statement and then support our efforts by signing, dating and returning the enclosed <B>updated
WHITE universal proxy card or voting instruction form</B> today.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS SOLICITATION IS BEING
MADE BY the PARTICIPANTS AND NOT ON BEHALF OF THE BOARD OR MANAGEMENT OF THE COMPANY. <FONT STYLE="text-transform: uppercase">The Politan
Parties Are</FONT> NOT AWARE OF ANY OTHER MATTERS TO BE BROUGHT BEFORE THE 2024 ANNUAL MEETING OTHER THAN AS DESCRIBED HEREIN. SHOULD
OTHER MATTERS, WHICH <FONT STYLE="text-transform: uppercase">the Politan Parties are</FONT> NOT AWARE OF A REASONABLE TIME BEFORE THIS
SOLICITATION, BE BROUGHT BEFORE THE 2024 ANNUAL MEETING, THE PERSONS NAMED AS PROXIES IN THE ENCLOSED <B>UPDATED WHITE UNIVERSAL PROXY
CARD OR VOTING INSTRUCTION FORM</B>&nbsp;WILL VOTE ON SUCH MATTERS IN THEIR DISCRETION.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">The
POLITAN Parties </FONT>URGE YOU TO VOTE <B>&ldquo;FOR&rdquo; </B>THE POLITAN NOMINEES AND <B>&ldquo;WITHHOLD&rdquo;</B> ON THE COMPANY
NOMINEES, BY FOLLOWING THE INSTRUCTIONS ON THE ENCLOSED <B>UPDATED WHITE UNIVERSAL PROXY CARD OR VOTING INSTRUCTION FORM</B>&nbsp;TODAY.
PLEASE SIGN, DATE AND RETURN THE <B>UPDATED WHITE UNIVERSAL PROXY CARD OR VOTING INSTRUCTION FORM</B>&nbsp;VOTING <B>&ldquo;FOR&rdquo;
</B>THE ELECTION OF THE POLITAN NOMINEES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">HOLDERS OF SHARES AS OF THE
RECORD DATE ARE URGED TO SUBMIT A <B>UPDATED WHITE UNIVERSAL PROXY CARD OR VOTING INSTRUCTION FORM</B>&nbsp;EVEN IF YOUR SHARES OF COMMON
STOCK WERE SOLD AFTER THE RECORD DATE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IF YOU HAVE ALREADY SENT A
PROXY CARD FURNISHED BY COMPANY MANAGEMENT OR THE BOARD, YOU MAY&nbsp;REVOKE THAT PROXY AND VOTE ON EACH OF THE PROPOSALS DESCRIBED IN
THIS PROXY STATEMENT BY SIGNING, DATING AND RETURNING THE ENCLOSED <B>UPDATED WHITE UNIVERSAL PROXY CARD OR VOTING INSTRUCTION FORM</B>.
THE LATEST DATED PROXY IS THE ONLY ONE THAT WILL BE COUNTED. ANY PROXY MAY&nbsp;BE REVOKED AT ANY TIME PRIOR TO THE 2024 ANNUAL MEETING
BY DELIVERING A WRITTEN NOTICE OF REVOCATION OR A LATER DATED PROXY FOR THE 2024 ANNUAL MEETING OR BY VOTING IN PERSON AT THE 2024 ANNUAL
MEETING.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>If you have previously voted on the WHITE universal
proxy card or voting instruction form for the annual meeting previously scheduled for July&nbsp;25, 2024, your vote is no longer valid.
To enable your votes to be validly counted for the 2024 Annual Meeting, you must resubmit your vote on the updated WHITE universal proxy
card or voting instruction form attached to this Proxy Statement for the 2024 Annual Meeting now scheduled to be held on September&nbsp;19,
2024.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Important Notice Regarding the Availability
of Proxy Materials for the 2024 Annual Meeting:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>This Proxy Statement and our updated WHITE
universal proxy card or voting instruction form are available at www.AdvanceMasimo.com</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>IMPORTANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>Your vote is important,
no matter how many shares of Common Stock you own. We urge you to sign, date, and return the enclosed updated WHITE universal proxy card
or voting instruction form today to vote FOR the election of the Politan Nominees and in accordance with the Politan Parties&rsquo; recommendations
on the other proposals on the agenda for the 2024 Annual Meeting.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&cir;</TD><TD STYLE="text-align: justify">If your shares of Common Stock are registered
                                            in your own name, please sign and date the enclosed updated <B>WHITE</B> universal proxy
                                            card and return it to Politan c/o D.F.&nbsp;King&nbsp;&amp; Co.,&nbsp;Inc., 48 Wall Street,
                                            New York, New York 10005 (&ldquo;<U>D.F. King</U>&rdquo;) in the enclosed envelope today.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&cir;</TD><TD STYLE="text-align: justify">If your shares of Common Stock are held
                                            in a brokerage account you are considered the beneficial owner of the shares of Common Stock,
                                            and these proxy materials, together with a updated <B>WHITE</B> voting instruction form,
                                            are being forwarded to you by your broker. As a beneficial owner, if you wish to vote, you
                                            must instruct your broker how to vote. Your broker cannot vote your shares of Common Stock
                                            on your behalf without your instructions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&cir;</TD><TD STYLE="text-align: justify">Depending upon your broker, you may
                                            be able to vote either by toll-free telephone or by the Internet. Please refer to the enclosed
                                            voting form for instructions on how to vote electronically. You may also vote by signing,
                                            dating and returning the enclosed voting form.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">As we are using a &ldquo;universal&rdquo;
proxy card containing both of the Politan Nominees as well as the Company&rsquo;s nominees, there is no need to use any other proxy card
regardless of how you intend to vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>The Politan Parties strongly
urge you NOT to sign or return any universal proxy cards or voting instruction forms that you may receive from Masimo. If you return
the gold management proxy card marked &ldquo;withhold&rdquo; as a protest against the incumbent directors, it will revoke any proxy card
you may have sent to us previously.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">If you have any questions, require assistance
in voting your <B>updated WHITE universal proxy card or voting instruction form</B>, or need additional copies of Politan&rsquo;s proxy
materials, please contact D.F. King using the contact information provided here:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>D.F.&nbsp;King&nbsp;&amp; Co.,&nbsp;Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>48 Wall Street</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>New York, New York 10005</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Stockholders call toll-free: (888) 628-8208</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Banks and Brokers call: (212) 269-5550</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>By Email: <U>MASI@dfking.com</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Background
of the Solicitation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">The following is a chronology
of events leading up to this proxy solicitation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            August&nbsp;16, 2022, Politan filed a Schedule 13D publicly disclosing beneficial ownership
                                            of approximately 8.4% of the Company&rsquo;s then outstanding Common Stock. Politan made
                                            no public statements other than the Schedule 13D filing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Mr.&nbsp;Kiani
                                            agreed to meet Mr.&nbsp;Koffey for the first time on September&nbsp;2, 2022. Shortly thereafter
                                            on September&nbsp;9, 2022, the Company filed a Form&nbsp;8-K announcing that the Board had
                                            (i)&nbsp;approved a Rights Agreement and (ii)&nbsp;amended and restated the Company&rsquo;s
                                            bylaws to add new requirements for the nomination and election of directors by Stockholders
                                            that imposed highly burdensome requirements on investment fund Stockholders seeking to nominate
                                            directors (the &ldquo;<U>Bylaw Amendments</U>&rdquo; and the Company&rsquo;s restated bylaws,
                                            the &ldquo;<U>Third Amended and Restated Bylaws</U>&rdquo;). In the following months, Politan
                                            and its counsel privately tried to persuade the Company to rescind the Bylaw Amendments and
                                            modify the Company&rsquo;s employment agreement with Mr.&nbsp;Kiani (as amended, the &ldquo;<U>Employment
                                            Agreement</U>&rdquo;). Ultimately, on October&nbsp;21, 2022, Politan filed a complaint in
                                            the Delaware Court of Chancery (the &ldquo;<U>Court of Chancery</U>&rdquo;) against the Company
                                            and the Board to invalidate the Bylaw Amendments and certain provisions in the Employment
                                            Agreement (the &ldquo;<U>2022 Court of Chancery Action</U>&rdquo;). Following extensive motion
                                            practice and discovery requests, including the Company attempting to subpoena Politan&rsquo;s
                                            investors, the Court of Chancery issued several rulings in favor of Politan. Masimo then
                                            repealed the Bylaw Amendments and Mr.&nbsp;Kiani agreed to modifications in the Employment
                                            Agreement that allowed a majority of the Board to turn over in 2023 and 2024 without triggering
                                            a payment to Mr.&nbsp;Kiani. The judge noted that &ldquo;Politan blew this case out of the
                                            water.&rdquo; He further stated that &ldquo;[t]here should be zero doubt, however, that the
                                            repeal of the challenged advance notice bylaw provisions here had remarkable value and was,
                                            frankly, an extraordinary corporate benefit.&rdquo;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            May&nbsp;1, 2023, Politan nominated Michelle Brennan and Quentin Koffey for election to the
                                            Board at the 2023 Annual Meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            Friday, June&nbsp;23, 2023, preliminary vote totals indicated that Politan&rsquo;s nominees
                                            would both be elected to the Board at the upcoming Monday&rsquo;s 2023 Annual Meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            Saturday, June&nbsp;24, 2023, the Board met to delegate authority to Mr.&nbsp;Kiani to pursue
                                            and carry out a sale of the entire Company, without any obligation to provide process updates
                                            to the Board or to obtain any additional Board approvals to retain financial or other advisors.
                                            The Board also concurrently made determinations about the Lead Independent Director and committee
                                            assignments. To date, Ms.&nbsp;Brennan and Mr.&nbsp;Koffey have only been provided redacted
                                            minutes from this Board meeting. This Board decision occurred before the 2023 Annual Meeting
                                            without the knowledge or involvement of Ms.&nbsp;Brennan and Mr.&nbsp;Koffey, despite it
                                            having at that point been clear that they would almost certainly be elected to the Board
                                            in just two days. In fact, Ms.&nbsp;Brennan and Mr.&nbsp;Koffey did not even receive a substantive
                                            update about the process until the first in-person Board meeting, which occurred on October&nbsp;31,
                                            2023&mdash;more than four months after Mr.&nbsp;Kiani had started the sale process.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">At no point in 2023 after the June&nbsp;Board
meeting was the Board ever presented with any strategic options other than a full Company sale. By late October, Mr.&nbsp;Kiani had already
engaged financial advisors, contacted multiple financial sponsors and held multiple discussions in connection with a Company sale. Mr.&nbsp;Kiani
did so on behalf of the Company. Ultimately in January&nbsp;2024, Mr.&nbsp;Kiani told the full Board that he was unable to find a deal
on what he considered to be satisfactory terms. To date, the 2023 Newly-Elected Directors have still not been told what terms Mr.&nbsp;Kiani
was seeking in the transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            Monday, June&nbsp;26, 2023, the Company held the 2023 Annual Meeting at which the Stockholders
                                            elected the 2023 Newly-Elected Directors to replace two incumbent directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Promptly
                                            after the 2023 Annual Meeting, and regularly thereafter, the 2023 Newly-Elected Directors
                                            requested the opportunity to meet and speak with senior management, to receive and analyze
                                            information about the Company and its financial condition and operations, and to participate
                                            in other customary onboarding and orientation activities for new Board members. The Politan
                                            Parties believe that the Company failed to properly act on these requests. The 2023 Newly-Elected
                                            Directors believed that the absence of a customary onboarding made it difficult for them
                                            to engage in certain Board functions, such as review of regular disclosures to investors.
                                            The following is an illustrative set of examples of the challenges the 2023 Newly-Elected
                                            Directors faced in attempting to exercise oversight over the Company&rsquo;s operations:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&cir;</TD><TD STYLE="text-align: justify">In an effort to facilitate a more collaborative
                                            boardroom dynamic, on August&nbsp;28, 2023, Politan, through counsel, informed Masimo that
                                            it and the California State Teachers&rsquo; Retirement System intended to drop the 2022 Court
                                            of Chancery Action regarding the Employment Agreement without prejudice. The 2023 Newly-Elected
                                            Directors met Mr.&nbsp;Kiani in person on Friday, September&nbsp;1, 2023 (the day before
                                            Labor Day weekend, when the Company headquarters was nearly empty). They received an overview
                                            of Mr.&nbsp;Kiani&rsquo;s vision for the Company and toured the Company&rsquo;s discovery
                                            lab. They did not meet any other members of senior management. This was the sole onboarding
                                            that Ms.&nbsp;Brennan and Mr.&nbsp;Koffey received other than receiving prior Board books
                                            and Board meeting minutes. Notably, the Board books contained barely any financial information
                                            beyond the earnings presentations posted on the Company&rsquo;s website.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&cir;</TD><TD STYLE="text-align: justify">When the Audit Committee was asked to
                                            sign off on the Quarterly Report on Form&nbsp;10-Q for the second and third quarter of 2023
                                            and first quarter of 2024, Mr.&nbsp;Koffey declined in each case to do so, believing that,
                                            despite the numerous requests, he had not received sufficient financial and operational information
                                            regarding the Company to fully evaluate the information and analysis presented in the report.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&cir;</TD><TD STYLE="text-align: justify">On February&nbsp;26, 2024, the Board
                                            met to discuss and finalize the Company&rsquo;s Annual Report on Form&nbsp;10-K for the fiscal
                                            year ended December&nbsp;30, 2023 (the &ldquo;<U>2023 Annual Report</U>&rdquo;). The Company&rsquo;s
                                            management team discussed a draft of the 2023 Annual Report with the Board, but following
                                            such discussion, a majority of the independent directors of the Board were unwilling to sign
                                            the 2023 Annual Report until additional information that the 2023 Newly-Elected Directors
                                            had repeatedly requested was provided.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&cir;</TD><TD STYLE="text-align: justify">On February&nbsp;27, 2024, the Board
                                            reconvened to discuss the 2023 Annual Report in advance of the filing deadline. In one hour,
                                            brief presentations were made by the heads of Finance&nbsp;&amp; Accounting, Cybersecurity,
                                            Compliance, Quality, and Supply Chain. This was the first time that the full Board heard
                                            from these groups. The 2023 Newly-Elected Directors believed there was insufficient time
                                            for questions. At the conclusion of the management presentations, a majority of the Board
                                            signed the 2023 Annual Report, but the 2023 Newly-Elected Directors remained unwilling to
                                            approve the document given what they viewed as the extremely abbreviated nature of the presentations
                                            on important topics that raised concerns and about which there was not time for discussion
                                            or questions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&cir;</TD><TD STYLE="text-align: justify">In late 2023, the 2023 Newly-Elected
                                            Directors began asking to see a draft budget for FY 2024 so that the Board could review and
                                            comment prior to being asked for their approval. They were informed that no budget approval
                                            was required. The only budget information the 2023 Newly-Elected Directors were ever subsequently
                                            given was the same financial guidance provided publicly to the market. No draft or final
                                            budget was ever provided to the Board. The Board never approved a budget or even had the
                                            opportunity to provide input.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&cir;</TD><TD STYLE="text-align: justify">The Company purchased the consumer technology
                                            company Sound United for approximately $1.024 billion in 2022 and it subsequently experienced
                                            a significant deterioration in business performance. The Company&rsquo;s 2023 Annual Report
                                            disclosed a $10 million impairment with respect to the Sound United business segment (less
                                            than 1% of the purchase price). As a member of the Audit Committee, Mr.&nbsp;Koffey asked
                                            to review the impairment analysis multiple times. To date, he has never been able to review
                                            the Company&rsquo;s impairment analysis and does not know why only $10 million of impairment
                                            has been taken.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&cir;</TD><TD STYLE="text-align: justify">Following the dramatic decline in sales
                                            during the second quarter of 2023, the 2023 Newly-Elected Directors asked to speak with the
                                            head of U.S. sales for the Company&rsquo;s professional healthcare business. To date, they
                                            have never been able to speak with such executive and therefore have not been able to adequately
                                            learn about the discounting and bulk orders whose discontinuation appear to have dramatically
                                            impacted sales starting in the second quarter of 2023.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&cir;</TD><TD STYLE="text-align: justify">Following the dramatic decline in sales
                                            in the consumer division, the 2023 Newly-Elected Directors asked to speak with the head of
                                            the Company&rsquo;s consumer division. To date, they have never been able to speak with such
                                            executive other than to hear him present for approximately half an hour at a February&nbsp;2024
                                            Board meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&cir;</TD><TD STYLE="text-align: justify">From when they first joined the Board
                                            and repeated regularly thereafter, the 2023 Newly-Elected Directors asked to have onboarding
                                            sessions with the Company&rsquo;s heads of quality, compliance, and regulatory divisions.
                                            To date, they have not been granted an opportunity to speak with any of them, other than
                                            the single abbreviated evening session on February&nbsp;27, 2024 on the eve of signing the
                                            2023 Annual Report.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&cir;</TD><TD STYLE="text-align: justify">From when they first joined the Board
                                            and regularly thereafter, the 2023 Newly-Elected Directors have asked for any currently existing
                                            and available market studies, product roadmaps, or business cases for products sold by the
                                            Company in order to understand why certain products were launched. To be clear, the 2023
                                            Newly-Elected Directors did not ask management to create work products but rather asked management
                                            to pass along to the directors any already existing analysis that management had reviewed
                                            when making decisions to develop and launch products. To date, the 2023 Newly-Elected Directors
                                            have never seen any such materials.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&cir;</TD><TD STYLE="text-align: justify">From when they first joined the Board
                                            and regularly thereafter, the 2023 Newly-Elected Directors asked for information on research
                                            and development (&ldquo;<U>R&amp;D</U>&rdquo;) spending so they could understand how much
                                            was being spent on what initiatives. To date, they have never received any information on
                                            R&amp;D beyond the publicly disclosed consolidated R&amp;D number disclosed in the Company&rsquo;s
                                            quarterly reports and 2023 Annual Report. The 2023 Newly-Elected Directors made similar requests
                                            about cost of goods sold and selling, general, and administrative expenses and have similarly
                                            received no more detailed information than what has been publicly disclosed in the Company&rsquo;s
                                            quarterly reports and 2023 Annual Report.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&cir;</TD><TD STYLE="text-align: justify">As detailed below, the 2023 Newly-Elected
                                            Directors have consistently made requests to learn about the separation process that the
                                            Company&rsquo;s management is currently pursuing. Only following a formal request under Delaware
                                            law was such basic information as the name of the joint venture partner provided to the Board.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Prior
                                            to the 2023 Annual Meeting, from mid-February&nbsp;through March&nbsp;2023, the Board interviewed
                                            Rolf A. Classon and Robert A. Chapek. The majority of the Board later added each of them
                                            to the Board in November&nbsp;2023 and January&nbsp;2024, respectively.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">In
                                            August&nbsp;and September&nbsp;of 2023, Mr.&nbsp;Kiani and Eli Kammerman, Head of Investor
                                            Relations at the Company, made multiple public statements regarding the search for new directors
                                            which Politan believes were misleading. For example, on August&nbsp;8, 2023, Mr.&nbsp;Kiani
                                            noted that the Nominating Committee was &ldquo;starting a little bit from scratch&rdquo;
                                            on a search for new directors. On September&nbsp;8, 2023 Mr.&nbsp;Kammerman stated: &ldquo;the
                                            Board has a new head of the Nominating Committee, that&rsquo;s Craig Reynolds, one of&nbsp;the
                                            legacy Board members. And it also has a new member on that committee, Michelle&nbsp;Brennan,
                                            one of the people elected back in June. That committee is&nbsp;now engaged in&nbsp;evaluation
                                            and screening of potential new members. And as Joe Kiani said in our second quarter earnings
                                            call they&rsquo;re working to get seats number six and number seven filled as soon as possible.&rdquo;
                                            Yet at the time of these statements, the Nominating Committee had never even met once since
                                            the 2023 Annual Meeting. Further, the search firm that had been engaged by the Board to conduct
                                            a director candidate search was on hold and not reaching out to new director candidates.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&cir;</TD><TD STYLE="text-align: justify">On November&nbsp;3, 2023 the Board appointed
                                            Mr.&nbsp;Classon as a Class&nbsp;II director, over the objections of the 2023 Newly-Elected
                                            Directors, who believed there was a total absence of a legitimate search process. The appointment
                                            of Mr.&nbsp;Classon had not been included in the agenda for the Board meeting. As noted above,
                                            the Board had previously interviewed Mr.&nbsp;Classon as a potential director in February&nbsp;and
                                            March&nbsp;of 2023.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&cir;</TD><TD STYLE="text-align: justify">On January&nbsp;15, 2024, the Board
                                            appointed Mr.&nbsp;Chapek as a Class&nbsp;I director, over the objections of the 2023 Newly-Elected
                                            Directors, who believed there was a total absence of a legitimate search process. Mr.&nbsp;Kiani
                                            referred Mr.&nbsp;Chapek to the Board as a director candidate, and, as noted above, the Board
                                            had previously interviewed Mr.&nbsp;Chapek as a potential director in the first quarter of
                                            2023.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Mr.&nbsp;Chapek was added to the same
director class as Ms.&nbsp;Brennan and Mr.&nbsp;Koffey, the class with the longest term remaining before re-election at the 2026 annual
meeting of Stockholders. Mr.&nbsp;Koffey voiced concerns that the Company was depriving Stockholders of the opportunity to evaluate and
vote on Mr.&nbsp;Chapek&rsquo;s nomination at the earliest reasonably practicable time, which would be the 2024 Annual Meeting. Consequently,
Mr.&nbsp;Koffey believed that Mr.&nbsp;Chapek should have been appointed as a Class&nbsp;II director and be up for election at the 2024
Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Beginning
                                            in January&nbsp;2024, Mr.&nbsp;Koffey and Mr.&nbsp;Kiani began preliminary discussions regarding
                                            potential strategic options for the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&cir;</TD><TD STYLE="text-align: justify">On January&nbsp;29, 2024, Mr.&nbsp;Kiani
                                            noted at a dinner with Mr.&nbsp;Koffey that his efforts to sell the Company on terms he found
                                            satisfactory had not materialized. Mr.&nbsp;Koffey made clear that Politan was strongly considering
                                            nominating director candidates for election at the 2024 Annual Meeting, given his frustration
                                            with the lack of meaningful engagement with the full Board since the 2023 Annual Meeting.
                                            Mr.&nbsp;Kiani proposed the Company purchase Politan&rsquo;s shares in the Company at a substantial
                                            premium in exchange for Politan agreeing to not purchase more shares and to never run a proxy
                                            contest in the future. Mr.&nbsp;Koffey flatly rejected this idea.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Mr.&nbsp;Kiani then revived the idea
proposed by Politan nearly a year earlier to separate the consumer business from the rest of the Company. Mr.&nbsp;Kiani proposed leaving
Masimo and heading the separated consumer-focused company on the condition that he controlled that company and that his departure not
be considered a resignation (and therefore result in forfeiture of certain compensation) under the terms of his Employment Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&cir;</TD><TD STYLE="text-align: justify">On January&nbsp;30, 2024, Mr.&nbsp;Koffey
                                            met with Mr.&nbsp;Kiani to further explore the proposed separation of the consumer business
                                            subject to the conditions Mr.&nbsp;Kiani had earlier raised and a commitment from Politan
                                            to forego nominating any director candidates during separation discussions. Mr.&nbsp;Koffey
                                            stated that as a single director on the Board, he was not in a position to negotiate or agree
                                            to Mr.&nbsp;Kiani&rsquo;s requests and suggested that it would be advisable for the whole
                                            Board to consider forming a special committee to negotiate the separation given the related
                                            party issues.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&cir;</TD><TD STYLE="text-align: justify">The next day, Mr.&nbsp;Koffey&rsquo;s
                                            counsel sent a summary of initial, high-level terms to serve as a basis for discussion between
                                            a Board special committee once formed and Mr.&nbsp;Kiani with respect to the proposed separation.
                                            Mr.&nbsp;Kiani&rsquo;s counsel responded on February&nbsp;3, 2024 with a substantially revised
                                            term sheet that significantly expanded on Mr.&nbsp;Kiani&rsquo;s earlier positions. Mr.&nbsp;Kiani&rsquo;s
                                            demands at this stage included: that the Company&rsquo;s corporate headquarters and corporate
                                            jet be included in the spun off assets; that the Company contribute up to $150 million in
                                            cash plus working capital to the new consumer entity; that the new entity have a class of
                                            20:1 supermajority voting stock that would confer majority voting control to Mr.&nbsp;Kiani,
                                            granted to him without additional consideration; that the new entity be incorporated in Nevada;
                                            that Mr.&nbsp;Kiani&rsquo;s departure to head the consumer business result in the immediate
                                            acceleration and pay out of the Special Payment in his Employment Agreement; that Mr.&nbsp;Kiani
                                            be Executive Chairman of the new entity but that a chief executive officer would also be
                                            selected and compensated; that certain unspecified intellectual property of the Company be
                                            shared or licensed between the Company and the new consumer entity; and that Mr.&nbsp;Kiani
                                            receive additional compensation to serve as a special advisor to the Company. Mr.&nbsp;Kiani
                                            later informed the Board verbally that he wanted the consumer business to take the name &ldquo;Masimo&rdquo;
                                            and that the remaining (historical) business of the Company should be renamed. Mr.&nbsp;Koffey
                                            responded with a call to Mr.&nbsp;Kiani again noting he was not in a position to negotiate
                                            or agree to the terms proposed by his counsel and reiterated that the Board should form a
                                            special committee to negotiate such a related party transaction with him. Mr.&nbsp;Kiani
                                            stated that he understood that there was no agreement, but that he wanted it to be clear
                                            what his requests were and he agreed to have the Board form a special committee.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            February&nbsp;13, 2024, the Board formed a special committee comprised of directors who represented
                                            a majority of the Board (the &ldquo;<U>Special Committee</U>&rdquo;) to evaluate related
                                            party aspects of the separation, including those relating to intellectual property, trademark
                                            use, governance control and other matters. The Special Committee consisted of Ms.&nbsp;Brennan,
                                            Mr.&nbsp;Classon, Mr.&nbsp;Koffey and Mr.&nbsp;Reynolds, and was empowered to evaluate and
                                            negotiate the separation of the consumer business and explore alternative transactions. The
                                            Special Committee unanimously decided to retain Sullivan&nbsp;&amp; Cromwell LLP to serve
                                            as its legal counsel, engaged Centerview Partners LLC to serve as its financial advisor and
                                            selected Mr.&nbsp;Koffey as its chairman. The Special Committee subsequently met regularly
                                            from mid-February&nbsp;through March&nbsp;of 2024.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&cir;</TD><TD STYLE="text-align: justify">On March&nbsp;11, 2024 the Special Committee
                                            unanimously agreed to send a revised term sheet that rejected the terms that Mr.&nbsp;Kiani
                                            had proposed and instead reflected the Special Committee&rsquo;s independent position on
                                            the separation transaction to Mr.&nbsp;Kiani.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The term sheet proposed an independent,
external advisory process to assist the Special Committee in determining the perimeter of intellectual property transfer and licensing.
The scope and duration of key intellectual property licenses between the two companies would be highly material to any transaction, and
if handled improperly, could result in a significant valuation impairment to the legacy healthcare business as well as give the consumer
products business significant advantages and influence over the legacy healthcare business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&cir;</TD><TD STYLE="text-align: justify">On March&nbsp;12, 2024, Mr.&nbsp;Kiani
                                            called Mr.&nbsp;Koffey and said that he would seek to dissolve the Special Committee. The
                                            Special Committee was later dissolved by the Board.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            March&nbsp;20, 2024, the Company entered into a confidentiality agreement with a potential
                                            joint venture partner in connection with the separation of the consumer business. The full
                                            Board knew nothing about the existence of the joint venture partner or any discussions that
                                            had occurred. The full Board was never notified that a confidentiality agreement had been
                                            entered into or that any confidential information had been exchanged until nearly eight weeks
                                            later on May&nbsp;13, 2024.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">After Mr.&nbsp;Koffey informed the
Company that the Politan Parties would be nominating candidates at the 2024 Annual Meeting, on March&nbsp;22, 2024, the Board approved
a press release announcing that the Board had authorized management to evaluate the separation and the expectation that Mr.&nbsp;Kiani
would remain Chairman and Chief Executive Officer of the Company <I>and</I> be named chairman of the newly separated company. The full
Board did not receive a draft of the press release until the Board meeting had commenced, and the meeting agenda made no mention of a
vote on any matter, let alone authorizing management to evaluate the separation of the consumer business. The press release was approved
over the objections of the 2023 Newly-Elected Directors. Neither the Special Committee nor its advisors were shown the draft release
prior to its being presented to the Board and its issuance. Furthermore, the full Board remained unaware that a joint venture proposal
was being considered by management in lieu of a spin-off. The full Board was also unaware that discussions with a potential joint venture
partner were occurring and that the confidentiality agreement with such party had been signed the previous week. At this same Board meeting,
Mr.&nbsp;Kiani stated that he would pursue the same separation of the consumer business that the Special Committee had rejected, but
would not need to purchase control of the new entity and could therefore dissolve the Special Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            March&nbsp;25, 2024, the Politan Parties, through counsel, submitted to the Company a notice
                                            nominating William Jellison and Darlene Solomon for election as independent Class&nbsp;II
                                            directors at the 2024 Annual Meeting. Neither Mr.&nbsp;Jellison nor Dr.&nbsp;Solomon have
                                            any pre-existing relationship with Politan or any of Masimo&rsquo;s Board members and were
                                            identified via a nationally recognized search firm. The Politan Parties believe that the
                                            Politan Nominees will bring crucial expertise and an independent perspective that is sorely
                                            needed on the Board. In disclosing their nominees, the Politan Parties also announced their
                                            support of a strategic review of the separation of the consumer business, while also noting
                                            that they have &ldquo;serious concerns given the lack of basic governance and oversight we
                                            have observed since joining the Board.&rdquo; The Politan Parties also stated that they have
                                            &ldquo;serious concerns that Mr.&nbsp;Kiani, without proper oversight, will seek to push
                                            through a spin-off with poor corporate governance and intellectual property arrangements
                                            where assets are allocated in such a manner designed to maintain his control and influence
                                            of both separated companies.&rdquo;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The release specifically stated that
the two highly qualified Politan Nominees could be added to the Board immediately, without undertaking a costly and distracting proxy
contest and without removing any of the then-incumbent directors, including Mr.&nbsp;Kiani.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Also
                                            on March&nbsp;25, 2024, members of the full Board learned for the first time through Mr.&nbsp;Kiani&rsquo;s
                                            interviews with the media that the Company had been approached by a potential joint venture
                                            partner in the consumer business. As reported in the <I>Wall Street Journal</I>, Mr.&nbsp;Kiani
                                            stated &ldquo;the company&hellip;has been approached by a potential partner&hellip;a joint
                                            venture would likely be much faster.&rdquo;<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>1
                                            </SUP></FONT>Mr.&nbsp;Kiani repeated these comments in a television interview on CNBC later
                                            that day, noting that &ldquo;over the weekend, we&rsquo;ve been discussing with a group that
                                            came forward after they saw our announcement&hellip; maybe we do a joint venture with them.&rdquo;
                                            As noted above, at the time of the Mr.&nbsp;Kiani&rsquo;s commentary, the full Board had
                                            not yet been told of the existence of a potential joint venture partner or that such joint
                                            venture partner had already signed a non-disclosure agreement on March&nbsp;20, 2024.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Despite multiple requests after the
public disclosure of the joint venture partner&rsquo;s existence, Mr.&nbsp;Kiani refused to disclose the identity of the potential joint
venture partner to the full Board until after Mr.&nbsp;Koffey demanded that information by exercising his rights as a director under
Section&nbsp;220 of the Delaware General Corporation Law (the &ldquo;<U>DGCL</U>&rdquo;). For example, Mr.&nbsp;Kiani refused to disclose
the identity of the potential joint venture partner &mdash; after the Company had already entered into a term sheet with the potential
joint venture partner &mdash; unless directors signed NDAs with the Company in their personal capacities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            March&nbsp;26, 2024, Mr.&nbsp;Koffey on behalf of Politan wrote to the Board to advocate
                                            that the Company should not take any actions prior to the 2024 Annual Meeting that could
                                            negatively impact shareholder election rights. The Company&rsquo;s legacy classified Board
                                            structure meant that it was fundamental for Stockholders to be able to contest sequential
                                            annual elections.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            April&nbsp;2, 2024, Politan and the Company entered into a framework agreement containing
                                            certain use and confidentiality restrictions in connection with the Board&rsquo;s proposed
                                            discussions with the Politan Nominees. In the weeks that followed, the Politan Nominees individually
                                            met with members of the Board, including Mr.&nbsp;Kiani.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>











<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP></FONT></TD><TD STYLE="text-align: justify">Ben
                                            Glickman, <I>Masimo May Look at Joint Venture for Consumer Split, CEO Says</I>, WALL ST.
                                            J. (March 25, 2024, 1:59 PM), https://www.wsj.com/business/masimo-may-look-at-joint-venture-for-consumer-split-ceo-says-1e0f2b4c.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            April&nbsp;4, 2024, Mr.&nbsp;Reynolds, Mr.&nbsp;Classon and Mr.&nbsp;Chapek called Mr.&nbsp;Koffey
                                            to propose a settlement arrangement to the proxy contest: in return for agreeing to add Mr.&nbsp;Jellison
                                            and Dr.&nbsp;Solomon to the Board, the three directors proposed that Politan agree that Mr.&nbsp;Kiani
                                            would resign as Chief Executive Officer of the Company and assume the role of Executive Chairman
                                            of a new entity holding the consumer business that would in the separation take the corporate
                                            headquarters and jet, $150 million in cash, a full acceleration and payment of Mr.&nbsp;Kiani&rsquo;s
                                            special payment under his Employment Agreement (of approximately $400 million at the time),
                                            the pre-selection of Mr.&nbsp;Kiani&rsquo;s preferred law firm Knobbe, Martens, Olson&nbsp;&amp;
                                            Bear to represent the Board in the separation of the Company&rsquo;s intellectual property,
                                            and Politan&rsquo;s abandonment of any remaining challenges in the Court of Chancery to Mr.&nbsp;Kiani&rsquo;s
                                            compensation arrangement. Mr.&nbsp;Koffey declined to agree to these terms given the restrictions
                                            they could impose on the independence of the Board and the potential impact they could have
                                            on long-term shareholder value, especially the lack of independent oversight of the separation
                                            of the Company&rsquo;s intellectual property.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            April&nbsp;25, 2024, in advance of the April&nbsp;30, 2024 Board meeting, Mr.&nbsp;Koffey
                                            became aware that Company management was seeking to enter into a binding agreement regarding
                                            the sale/joint venture of the consumer business in June&nbsp;2024 and therefore prior to
                                            the annual meeting, which was proposed for the end of July.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Also
                                            on April&nbsp;25, 2024, Mr.&nbsp;Koffey emailed the Company&rsquo;s Corporate Secretary to
                                            propose that items be added to the agenda at the next Board meeting, including the following:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&cir;</TD><TD STYLE="text-align: justify">that the Company hold its annual meeting
                                            earlier in the year than the proposed July&nbsp;25, 2024 date (which would fall approximately
                                            thirteen months after the 2023 Annual Meeting and was therefore the latest permissible day
                                            under Delaware law and the Bylaws), which timing of the meeting in July&nbsp;was outside
                                            the Company&rsquo;s historical practice;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&cir;</TD><TD STYLE="text-align: justify">that the Company would not enter into
                                            any binding agreements or joint ventures relating to the separation of the consumer business
                                            until after the conclusion of the 2024 Annual Meeting; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&cir;</TD><TD STYLE="text-align: justify">that Mr.&nbsp;Kiani and Mr.&nbsp;Reynolds
                                            switch director classes such that Mr.&nbsp;Reynolds be nominated as a Class&nbsp;II director
                                            nominee up for election at the 2024 Annual Meeting and Mr.&nbsp;Kiani become a Class&nbsp;III
                                            director up for election at the 2025 Annual Meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Mr.&nbsp;Koffey contended that this director
class realignment proposal would have the benefit of allowing Mr.&nbsp;Kiani to remain on the Board even if the proxy contest with Politan
were to continue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            April&nbsp;29, 2024, the Company disclosed that 2,972,778 shares of Common Stock<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>2
                                            </SUP></FONT>(valued at the time at roughly $400 million and representing nearly 6% of the
                                            Common Stock outstanding) beneficially owned by Mr.&nbsp;Kiani had been pledged as collateral
                                            for personal loans, which total was more than seven times the 400,000 shares that were disclosed
                                            as pledged before the 2023 Annual Meeting and was approximately 75% of his stock ownership.
                                            The full Board only learned about this increased pledge when the draft of the April&nbsp;29,
                                            2024 filing was circulated to the Board a few days earlier and no additional information
                                            about the pledge was ever provided. The current Compensation Committee never voted to approve
                                            Mr.&nbsp;Kiani&rsquo;s increase in pledged shares.<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>3
                                            </SUP></FONT>The Company Proxy Statement disclosed that Mr.&nbsp;Kiani &ldquo;sought and
                                            received the approval of the Compensation Committee prior to entering into this transaction
                                            [<I>i.e.</I>, the personal loan] in 2013&rdquo;. Other than the public disclosures, members
                                            of the current Board do not know the purpose for which Mr.&nbsp;Kiani&rsquo;s shares are
                                            pledged or what the terms of the pledge entail, including the ways in which Mr.&nbsp;Kiani
                                            could liquidate the shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            April&nbsp;30, 2024, the Board met and voted, over the objections of the 2023 Newly-Elected
                                            Directors, to reject Mr.&nbsp;Koffey&rsquo;s proposals made in writing to the Company&rsquo;s
                                            Corporate Secretary on April&nbsp;25, 2024.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Also
                                            on April&nbsp;30, 2024, the full Board was informed, for the first time, that the Company
                                            had, nearly six weeks earlier, received a civil investigative demand from the Department
                                            of Justice and a subpoena from the Securities and Exchange Commission (the &ldquo;<U>SEC</U>&rdquo;)
                                            on March&nbsp;25, 2024 and March&nbsp;26, 2024, respectively. The Company later publicly
                                            disclosed this information on May&nbsp;7, 2024, in the Company&rsquo;s Quarterly Report on
                                            Form&nbsp;10-Q (the &ldquo;<U>Q1 2024 10-Q</U>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Also
                                            on April&nbsp;30, 2024, the Board resolved to set the date of the Company&rsquo;s 2024 annual
                                            meeting of stockholders as July&nbsp;25, 2024 and the record date for such meeting as June&nbsp;13,
                                            2024.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            May&nbsp;2, 2024, Mr.&nbsp;Koffey sent a letter to Mr.&nbsp;Kiani to express his concerns
                                            with the Board&rsquo;s approach to the separation of the consumer business. Among other things,
                                            Mr.&nbsp;Koffey requested the identity of the potential joint venture partner and information
                                            about the status of negotiations and terms. Mr.&nbsp;Kiani later responded on May&nbsp;8,
                                            2024, declining to provide such basic information as even the identity of the joint venture
                                            partner, which prompted Mr.&nbsp;Koffey, in his capacity as a member of the Board, to submit
                                            that same day a books and records request pursuant to Section&nbsp;220 of the DGCL, regarding
                                            the potential separation (the &ldquo;<U>Koffey Records Request</U>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Two
                                            weeks later, on May&nbsp;16, 2024, the Board was for the first time provided with the name
                                            of the joint venture partner. In addition, the Board was provided with an executed non-binding
                                            term sheet between the Company and the joint venture partner. The Company Proxy Statement
                                            erroneously states that the term sheet was &ldquo;proposed&rdquo;; however, the term sheet
                                            had already been executed by Mr.&nbsp;Kiani and the joint venture partner a week earlier
                                            on May&nbsp;7, 2024, without the knowledge of the Board.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>2</SUP></FONT></TD><TD STYLE="text-align: justify">The
                                            Company Proxy Statement later disclosed this number had dropped to 2,447,778, p. 73, which
                                            is still more than six times the amount disclosed prior to the 2023 Annual Meeting.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>3</SUP></FONT></TD><TD STYLE="text-align: justify">Company
                                            Proxy Statement, p. 65 (&ldquo;In addition, all pledging of our equity securities by our
                                            executive officers and members of our Board must be pre-approved by the Compensation Committee...&rdquo;).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company and a director aligned
with Mr.&nbsp;Kiani made separate books and records requests of Mr.&nbsp;Koffey regarding the proposed separation, which Mr.&nbsp;Koffey
believes to be retaliatory and inappropriate. On June&nbsp;11, 2024, the Company demanded that Mr.&nbsp;Koffey turn over his personal
and business emails and texts regarding the potential separation, and on June&nbsp;13, 2024, Mr.&nbsp;Reynolds requested from Mr.&nbsp;Koffey
materials including those related to the Special Committee&rsquo;s work. Mr.&nbsp;Koffey&rsquo;s counsel wrote to the Company&rsquo;s
counsel on June&nbsp;17, 2024: &ldquo;instead of providing Mr.&nbsp;Koffey with even basic information about the Potential Transactions,
the Company (aided by a director aligned with Joe Kiani), through the Reynolds Demand, has demanded that Mr.&nbsp;Koffey produce his
emails and text messages regarding the Special Committee process, including privileged communications with counsel to the Special Committee
and communications among independent directors reflecting their views of Mr.&nbsp;Kiani&rsquo;s negotiating positions.&rdquo; Mr.&nbsp;Koffey,
through counsel, said that although he believed the requests were retaliatory in nature and that neither the Company nor Mr.&nbsp;Reynolds
had the authority to demand the information requested from him, he would provide such materials (which are limited, given the extremely
small amount of information he had received from the Company at the time) to the independent directors so long as the independent directors
committed not to share them with management. On June&nbsp;19, 2024, the Company produced a batch of materials to Mr.&nbsp;Koffey relating
to the Koffey Records Request, and at the time of the filing of this Proxy Statement, those materials were under review.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            May&nbsp;6, 2024, in a phone call with Mr.&nbsp;Koffey, Mr.&nbsp;Reynolds communicated that
                                            the Company was prepared to appoint Mr.&nbsp;Jellison to the Board as a Class&nbsp;II director
                                            in exchange for Politan withdrawing Dr.&nbsp;Solomon&rsquo;s nomination and ending its proxy
                                            contest. The next day, Mr.&nbsp;Reynolds informed Mr.&nbsp;Koffey in a text message that
                                            Mr.&nbsp;Koffey had to respond by email to the proposal by 4:00 p.m.&nbsp;Eastern Time on
                                            May&nbsp;7, 2024 (less than 24 hours after Mr.&nbsp;Reynolds first relayed the terms).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            May&nbsp;8, 2024, the Company announced the resignation of Mr.&nbsp;Classon as a director,
                                            effective May&nbsp;10, 2024.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            May&nbsp;9, 2024, Mr.&nbsp;Reynolds, in his capacity as the lead independent director of
                                            the Board, sent a letter, which he promptly made public, to Mr.&nbsp;Koffey in which Mr.&nbsp;Reynolds
                                            proposed appointing Mr.&nbsp;Jellison to the Board in exchange for Politan withdrawing Dr.&nbsp;Solomon&rsquo;s
                                            nomination and ending its proxy contest (the &ldquo;<U>May&nbsp;9 Proposal</U>&rdquo;). Mr.&nbsp;Koffey,
                                            on behalf of Politan, responded in a letter that same day to Mr.&nbsp;Reynolds, stating that
                                            the May&nbsp;9 Proposal &ldquo;falls well short of resolving the fundamental governance problems
                                            at Masimo, while simultaneously introducing others.&rdquo; The response to the May&nbsp;9
                                            Proposal further noted that &ldquo;seating one Politan nominee will simply deadlock the Board&mdash;something
                                            broadly criticized by governance experts which would merely continue the status quo under
                                            which Mr.&nbsp;Kiani can do whatever he wants however he wants with no Board oversight&rdquo;
                                            and concluded that there is a &ldquo;straightforward and clear solution&rdquo; to Masimo&rsquo;s
                                            need for &ldquo;a majority of truly independent directors,&rdquo; specifically the appointment
                                            of both Mr.&nbsp;Jellison and Dr.&nbsp;Solomon to the Board immediately. If Mr.&nbsp;Jellison
                                            and Dr.&nbsp;Solomon were appointed, Politan stated that it would not oppose the re-election
                                            of Mr.&nbsp;Kiani to the Board.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            May&nbsp;15, 2024, Mr.&nbsp;Kiani was interviewed at a Bank of America Healthcare Conference
                                            and discussed the potential timing for a joint venture transaction to effect the proposed
                                            separation. Mr.&nbsp;Kiani said:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>&ldquo;We may have been able to
even do a JV before the shareholder meeting because the JV wants to get it done by June&nbsp;25, but right now, the activist is pushing
back, threatening litigation. So I don&rsquo;t want to get into a lawsuit. I&rsquo;d rather wait until after the proxy to do it. Hopefully,
they won&rsquo;t go away. I always say the most important thing to any deal is momentum. And so I hate the fact we&rsquo;re going to
lose momentum, and I hope that will go away. But I thought the shareholders wanted that. And if they do, they should tell him to back
off because it&rsquo;s threatening to sue us if we try to do the JV before the proxy, and I don&rsquo;t want to do it.&rdquo;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            May&nbsp;16, 2024, at the same meeting at which the identity of the potential joint venture
                                            partner was made known to the full Board for the first time, the Board voted, over the objections
                                            of the 2023 Newly-Elected Directors, to propose Christopher G. Chavez as a nominee for election
                                            at the 2024 Annual Meeting to fill the Class&nbsp;II director position left vacant by Mr.&nbsp;Classon&rsquo;s
                                            resignation. Mr.&nbsp;Kiani had referred Mr.&nbsp;Chavez to the Board as a director candidate.
                                            The Nominating Committee had not met to discuss Mr.&nbsp;Chavez&rsquo;s nomination or consider
                                            alternative candidates. On May&nbsp;23, 2024, in an email to Mr.&nbsp;Koffey, Mr.&nbsp;Reynolds
                                            proposed appointing Mr.&nbsp;Jellison and Mr.&nbsp;Chavez to the Board, which would expand
                                            the Board to seven members, in exchange for Politan withdrawing Dr.&nbsp;Solomon&rsquo;s
                                            nomination and ending its proxy contest. Mr.&nbsp;Reynolds offered to arrange a meeting between
                                            Mr.&nbsp;Koffey and Mr.&nbsp;Chavez. Mr.&nbsp;Koffey responded by offering to meet with Mr.&nbsp;Chavez,
                                            and the two spoke for over an hour on May&nbsp;27, 2024. On May&nbsp;29, 2024, in a phone
                                            call with Mr.&nbsp;Reynolds and Mr.&nbsp;Chapek, Mr.&nbsp;Koffey stated that Politan would
                                            not support adding Mr.&nbsp;Chavez to the Board. On that same call, Mr.&nbsp;Koffey reiterated
                                            Politan&rsquo;s proposal that Mr.&nbsp;Jellison and Dr.&nbsp;Solomon be added to the Board
                                            and that Mr.&nbsp;Kiani could remain on the Board and the proxy solicitation would be over.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            May&nbsp;31, 2024, the Company issued a press release announcing its nomination of Mr.&nbsp;Chavez
                                            as a Class&nbsp;II director on the Board and said, &ldquo;members of the Board contacted
                                            and considered several candidates with skills and experiences that would enhance the Board&rsquo;s
                                            slate.&rdquo; As noted above, the Nominating Committee had not met or considered Mr.&nbsp;Chavez
                                            or any alternative candidates and had not nominated Mr.&nbsp;Chavez to the full Board (<I>see
                                            </I>references to the Nominating Committee and Mr.&nbsp;Chavez on May&nbsp;16, 2024, above).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            June&nbsp;5, 2024, the Company&rsquo;s Executive Vice President and Chief Financial Officer,
                                            Micah Young, discussed the proposed separation at the Jeffries 2024 Global Healthcare Conference,
                                            including the division of intellectual property between Masimo and the proposed separated
                                            consumer business. Politan viewed these comments as unusual and premature in that they did
                                            not reflect the analysis or input of the full Board with respect to the proposed separation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            June&nbsp;17, 2024, the Company filed the definitive version of the Company Proxy Statement
                                            with the SEC, followed by the Politan Parties&rsquo; original definitive proxy statement
                                            filed on June&nbsp;21, 2024.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            July&nbsp;3, 2024, Mr.&nbsp;Koffey, on behalf of Politan, wrote a letter to notify the Board
                                            that Politan believed, based on share movement and preliminary voting data available to Politan,
                                            that an investor had engaged in a trading strategy known as &ldquo;record date capture&rdquo;
                                            and &ldquo;empty voting&rdquo; that provides the investor the ability to vote shares with
                                            respect to which they do not have economic exposure (the &ldquo;<U>Empty Voting Letter</U>&rdquo;).
                                            Mr.&nbsp;Koffey requested that the Board set a new record date for the 2024 Annual Meeting,
                                            without postponing the date of the 2024 Annual Meeting, and to take other appropriate measures
                                            to investigate and address the empty voting scheme that Politan observed.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            July&nbsp;5, 2024, the Company&rsquo;s General Counsel responded to Mr.&nbsp;Koffey by email
                                            that the Company was looking into the matters described in the Empty Voting Letter and that
                                            there would be a Board meeting on the topic the following week.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            July&nbsp;8, 2024, Mr.&nbsp;Reynolds sent a letter to Mr.&nbsp;Koffey stating &ldquo;neither
                                            Mr.&nbsp;Kiani nor any other member of management or non-Politan member of the Board has
                                            ever had any agreement, arrangement or understanding related to the trading or voting of
                                            the shares in question.&rdquo;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Later
                                            that week, on July&nbsp;11, 2024, leading proxy advisory firm Glass, Lewis&nbsp;&amp; Co.
                                            (&ldquo;<U>Glass Lewis</U>&rdquo;) issued a recommendation that Stockholders vote in favor
                                            of the Politan Nominees. In its report, Glass Lewis identified an investor whose investment
                                            &ldquo;appear[s] to align with certain of the concerns raised by Politan&rdquo; in the Empty
                                            Voting Letter.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            July&nbsp;12, 2024, Mr.&nbsp;Koffey on behalf of Politan wrote a second letter to the Board
                                            relating to the empty voting issue and providing additional information to the Board. The
                                            letter requested that the Company take measures to minimize the effect of empty voting on
                                            the outcome of the 2024 Annual Meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            July&nbsp;15, 2024, another leading proxy advisory firm,&nbsp;Institutional Shareholder Services
                                            (&ldquo;<U>ISS</U>&rdquo;), joined Glass Lewis in recommending that Stockholders support
                                            the Politan Nominees at the 2024 Annual Meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Also
                                            on July&nbsp;15, 2024, Mr.&nbsp;Koffey on behalf of Politan wrote and made publicly available
                                            a letter to the Board detailing its efforts since July&nbsp;3, 2024 to make the Board aware
                                            of the empty voting issue and take appropriate corrective action. The letter called for the
                                            Board to set the record date as July&nbsp;18, 2024 and for the 2024 Annual Meeting to be
                                            held no later than August&nbsp;5, 2024, noting that both Delaware law and the Bylaws require
                                            a meeting to be held within 13 months of the date on which the 2023 Annual Meeting was held
                                            (which was June&nbsp;26, 2023).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Later
                                            on July&nbsp;15, 2024, the Board met and, over the objections of the two 2023 Newly-Elected
                                            Directors, voted to delay the 2024 Annual Meeting until September&nbsp;19, 2024 and to bring
                                            a lawsuit against Politan, the Politan Nominees and the 2023 Newly-Elected Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Also on July 15, 2024, the Company filed a verified complaint in the U.S. District Court for the
                                                                                                         Central District of California against the Politan Parties, Ms. Brennan and the Politan Nominees (the &ldquo;<U>California
                                                                                                         Action</U>&rdquo;).<SUP>4</SUP> The Company&rsquo;s complaint asserts, among other claims, that defendants violated the Exchange Act
                                                                                                         because the Politan Parties&rsquo; proxy materials allegedly contained false and misleading statements; and breach of fiduciary duty
                                                                                                         claims against the 2023 Newly-Elected Directors. Politan believes that the complaint is completely without merit and denies all of
                                                                                                         the allegations in the complaint. The Company seeks, among other relief: (i) a declaration that the Politan Parties&rsquo; proxy
                                                                                                         materials violated the Exchange Act; <FONT STYLE="background-color: white">(ii) a declaration that the Politan Parties&rsquo;
                                                                                                         nomination notice to the Company on March 25, 2024 did not comply with the Bylaws; (iii) an injunction preventing the Politan
                                                                                                         Parties from voting any proxies received by means of allegedly misleading proxy materials; and </FONT>(iv) an order invalidating any
                                                                                                         such proxies. The Company&rsquo;s complaint includes a false and defamatory allegation that Mr. Koffey conspired with a law firm
                                                                                                         that is representing plaintiffs in a lawsuit against the Company and the Board (the &ldquo;<U>Conspiracy Allegation</U>&rdquo;)
                                                                                                         &mdash; an allegation that Politan categorically denies. Moreover, since the Company initiated the California Action against
                                                                                                         Politan, it came to light that the Company&rsquo;s outside legal counsel: (x) based its Conspiracy Allegation on statements from
                                                                                                         unnamed sources received from a third-party opposition research firm, (y) never spoke to the unnamed sources themselves to verify
                                                                                                         the Conspiracy Allegation before initiating the California Action and (z) does not even know the identity of the unnamed
                                                                                                         sources.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            July&nbsp;16, 2024, the Company announced that it had postponed the 2024 Annual Meeting to
                                            September&nbsp;19, 2024.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            July&nbsp;17, 2024, Politan filed a verified complaint in the Court of Chancery to commence
                                            legal action against the Company, Mr.&nbsp;Kiani, Mr.&nbsp;Reynolds and Mr.&nbsp;Chapek (the
                                            &ldquo;<U>2024 Court of Chancery Action</U>&rdquo;).<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>5
                                            </SUP></FONT>Politan alleged certain breaches of Delaware law by the defendants and sought
                                            relief including: (i)&nbsp;a determination that the defendant directors breached their fiduciary
                                            duties by postponing the 2024 Annual Meeting from July&nbsp;25, 2024 to September&nbsp;19,
                                            2024, (ii)&nbsp;an order that the Company must set the record date for the 2024 Annual Meeting,
                                            and hold the 2024 Annual Meeting, as soon as possible, (iii)&nbsp;a declaration that the
                                            Company and the 2024 Director Defendants are estopped from rejecting Politan&rsquo;s nominations
                                            of the Politan Nominees and (iv)&nbsp;<FONT STYLE="background-color: white">an appropriate
                                            status quo order to prevent the defendants from taking any material action with respect to
                                            the business of the Company before the 2024 Annual Meeting</FONT>. On July&nbsp;19, 2024,
                                            the Court of Chancery declined to order that the 2024 Annual Meeting should be held earlier
                                            than September&nbsp;19, 2024, but granted Politan&rsquo;s motion to expedite the action and
                                            indicated it would schedule a hearing for early September&nbsp;to address issues relating
                                            to the 2024 Annual Meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>4</SUP></FONT></TD><TD STYLE="text-align: justify"><I>Masimo
                                            Corporation v. Politan Capital Management LP, et al.</I>, Case No. 8:24-CV-1568.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>5</SUP></FONT></TD><TD STYLE="text-align: justify"><I>Politan
                                            Capital Management LP v. Joe E. Kiani, Craig B. Reynolds, and Robert Chapek, and Masimo Corporation</I>,
                                            Case Number 2024-0755.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            July&nbsp;18, 2024, the Company filed a motion for preliminary injunction requesting that
                                            the Court enjoin the defendants from voting any proxies solicited by them in violation of
                                            Section&nbsp;14(a)&nbsp;of the Exchange Act and Rule&nbsp;14a-19. The Company also filed
                                            a motion seeking expedited discovery in aid of its preliminary injunction motion.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            July&nbsp;19, 2024, Politan filed supplemental proxy materials with the SEC as definitive
                                            additional proxy materials (the &ldquo;<U>Supplemental Materials</U>&rdquo;), including the
                                            California Complaint, in which Politan publicly denied all allegations in the California
                                            Complaint. Politan incorporates the Supplemental Materials by reference in this Proxy Statement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            July&nbsp;22, 2024, the Politan Parties re-submitted to the Company a notice nominating the
                                            Politan Nominees for election at the 2024 Annual Meeting and making the other proposals previously
                                            submitted in the notice to the Company delivered on March&nbsp;25, 2024.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">On
                                            August&nbsp;6, 2024, the Politan Parties filed this updated Proxy Statement with the SEC.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Reasons
for the Solicitation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Politan initially invested
in Masimo with the hope that we could work collaboratively with the Company to help maximize Masimo&rsquo;s significant potential and
create long-term sustainable value for Stockholders. Unfortunately, Politan&rsquo;s efforts were met almost immediately with an exceptionally
hostile response, including the adoption of defensive Bylaw Amendments designed to block Stockholder director nominations and the refusal
to constructively engage on any level. These Bylaw Amendments were later abolished following a series of losses by the Company in the
Court of Chancery (see the section entitled &ldquo;<FONT STYLE="text-transform: uppercase">Background of the Solicitation</FONT>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">At the 2023 Annual Meeting,
Stockholders overwhelmingly elected Politan nominees Michelle Brennan and Quentin Koffey to the Board. Following this clear mandate from
Stockholders, we were optimistic that we could engage productively with the rest of the Board to drive positive change. Instead, our
efforts were continually rebuffed. The leadership of the Board refused to provide Ms.&nbsp;Brennan and Mr.&nbsp;Koffey basic information
or access to management, repeatedly held meetings of directors excluding them, and refused to even consider allowing any review of any
aspect of strategy, product portfolio, cost structure, or capital allocation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">In March&nbsp;2024, Masimo
announced that the Board had authorized an evaluation of the separation of the consumer business. Politan supports a strategic review
to evaluate the separation of the consumer business. However, Politan has serious concerns given the lack of basic governance and oversight
Politan has observed since joining the Board. We believe that this absence of oversight has been damaging to Stockholders and the Company,
and must be remedied in order to assure Stockholders that any potential transaction, including the separation of the consumer business,
is conducted with their best interests in mind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">If one or both of the Politan
Nominees are elected to the Board, among other things, they would seek to provide independent oversight of management. Together with
the 2023 Newly-Elected Directors, the Politan Nominees, if elected, would constitute a majority of the Board although neither Politan
Nominee has predetermined how they would vote on any specific matters that might be presented to the Board. Further, each Politan Nominee
was identified and contacted through a nationally recognized search firm and has no pre-existing relationship with anyone at Politan
or on the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">We believe that Masimo clearly
and urgently needs a majority of truly independent directors, especially given the importance of not only ensuring the Company follows
through on its announcement to evaluate the separation of the consumer business of the consumer business, but also to make sure it is
done properly without bias or favor shown to Mr.&nbsp;Kiani. For example, in the event of a separation of the consumer business, there
would be vital considerations around the allocation of the Company&rsquo;s intellectual property and the control of a potential newly
created entity. We are concerned that Mr.&nbsp;Kiani, without proper oversight, will seek to push through the separation of the consumer
business with poor corporate governance and intellectual property arrangements where assets are allocated in such a manner designed to
maintain his own control and influence of both separated companies. Additionally, the Company&rsquo;s announcement of the separation
of the consumer business to the media in late March&nbsp;2024 while concurrently withholding information from directors underscores why
Politan believes that it is more important than ever for the Board to be comprised of a majority of truly independent directors. We believe
that the Politan Nominees will provide additional independent voices in the boardroom, bring extensive industry-related experience and
expertise to the Board and provide valuable insight on research and development, strategy, sustainability and operational challenges
faced by companies focused on commercialization of technology innovations. We believe that, together with the 2023 Newly-Elected Directors,
the Politan Nominees will help instill accountability and drive improved performance and governance &mdash; and ultimately enhanced value
for all Stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Proposal
One</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ELECTION OF DIRECTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Company currently has a
classified Board of five directors divided into three classes. Class&nbsp;I includes three directors (Ms.&nbsp;Brennan, Mr.&nbsp;Koffey
and Mr.&nbsp;Chapek). Class&nbsp;II includes one director (Mr.&nbsp;Kiani) and, since Mr.&nbsp;Classon&rsquo;s resignation, one vacant
director position. Class&nbsp;III includes one director (Mr.&nbsp;Reynolds). The terms of the Class&nbsp;II directors are set to expire
at the 2024 Annual Meeting. The Record Stockholder nominated the Politan Nominees to replace Mr.&nbsp;Kiani and to fill the vacant Class&nbsp;II
director position formerly occupied by Mr.&nbsp;Classon. The Company nominated Mr.&nbsp;Kiani for reelection to his Class&nbsp;II director
position and Mr.&nbsp;Chavez to fill the vacant Class&nbsp;II director position formerly occupied by Mr.&nbsp;Classon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Board is in the process
of a phased declassification. From and after the 2024 Annual Meeting, the directors in each class will be elected for terms of office
of one-year, expiring at the following annual meeting of Stockholders. Following the expiration of the terms of the Class&nbsp;I directors
at the annual meeting of Stockholders in 2026, the Board will thereafter be completely declassified such that all directors will be elected
for a term of office expiring at each annual meeting of Stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">We are seeking your support
at the 2024 Annual Meeting to elect both Politan Nominees, William Jellison and Darlene Solomon, for terms ending at the 2025 Annual
Meeting. Assuming the Politan Nominees receive sufficient votes to be elected to the Board, your vote to elect the Politan Nominees will
have the legal effect of replacing two incumbent directors of the Company with the Politan Nominees. If elected, the Politan Nominees,
together with the 2023 Newly-Elected Directors, will represent a majority of the members of the Board. If elected, the Politan Nominees,
subject to their fiduciary duties as directors, will seek to work collaboratively with the other members of the Board to execute a strategic
review process, which is described in more detail herein. There is no assurance that any incumbent director will serve as a director
if the Politan Nominees are elected to the Board. You should refer to the Company Proxy Statement for the names, background, qualifications
and other information concerning the Company&rsquo;s nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">This Proxy Statement is soliciting
proxies to elect the two Politan Nominees. As part of the Nomination and Proposal Notice, we have provided the required notice to the
Company pursuant to the universal proxy rules, including Rule&nbsp;14a-19(a)(1)&nbsp;under the Securities Exchange Act of 1934, as amended
(the &ldquo;<U>Exchange Act</U>&rdquo;), and we intend to solicit the holders of Common Stock representing at least 67% of the voting
power of Common Stock entitled to vote on the election of directors in support of director nominees other than the Company&rsquo;s nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>THE POLITAN NOMINEES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The following description sets
forth the name, age, business address, present principal occupation, and employment and material occupations, positions, offices or employments
for the past five years of the Politan Nominees. The nomination was made in a timely manner and in compliance with the applicable provisions
of the Company&rsquo;s governing instruments. The specific experience, qualifications, attributes and skills that led us to conclude
that the Politan Nominees should serve as directors of the Company are also set forth below. This information has been furnished to us
by the Politan Nominees. Each of the Politan Nominees is a citizen of the United States of America.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>William
Jellison</B></FONT>, age 66, has over 40 years of business experience including extensive experience in the medical technology industry.
He is currently an independent business consultant and M&amp;A advisor for Astor Place Holdings and serves on the boards of Anika Therapeutics,&nbsp;Inc.
(NASDAQ: ANIK), Young Innovations,&nbsp;Inc. and Avient Corporation (NYSE: AVNT), where he is an independent director. At Anika, Mr.&nbsp;Jellison
serves as a member of the Audit Committee and the Capital Allocation Committee, while at Avient, he serves as Chairman of the Audit Committee
and is a member of the Environmental, Health and Safety Committee. Mr.&nbsp;Jellison previously served as vice president and chief financial
officer of Stryker Corporation until 2016, where he was responsible for all areas of international finance, including accounting, planning
and analysis, SEC reporting, acquisition valuations, internal audit, tax and treasury activity. Prior to Stryker Corporation, Mr.&nbsp;Jellison
spent 15 years at Dentsply International in a number of leadership positions, including Chief Financial Officer, as well as Senior Vice
President with full P&amp;L responsibilities for some of Dentsply International&rsquo;s operating divisions in the United States, Europe
and Asia. Mr.&nbsp;Jellison began his career with Donnelly Corporation where he held multiple financial management and executive positions,
including Vice President of Finance, Treasurer and Corporate Controller. Mr.&nbsp;Jellison holds a bachelor&rsquo;s degree in Business
Administration from Hope College in Holland, Michigan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">We believe that Mr.&nbsp;Jellison&rsquo;s
experience serving on other public company boards of directors, his extensive experience in the medical technology industry, his general
management experience, and his corporate strategy experience would add significant value to the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">As of the date hereof, Mr.&nbsp;Jellison
does not own any securities of the Company and has not entered into any transactions in the securities of the Company during the past
two years. The principal business address of Mr.&nbsp;Jellison is 9946 W. Gull Lake Dr., Richland, Michigan 49083.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Darlene
Solomon, </B></FONT>age 65, is a proven business and R&amp;D strategy expert having recently completed a 39-year career at Agilent Technologies,&nbsp;Inc.
(NYSE: A) (&ldquo;<U>Agilent</U>&rdquo;), with nearly 20 years as Chief Technology Officer and Senior Vice President. In this role, Dr.&nbsp;Solomon
oversaw Agilent Research Laboratories, which focuses on high-impact, longer-range research in support of the company&rsquo;s sustained
core and adjacent business growth, as well as Agilent&rsquo;s programs in university relations, external research, and venture investment.
As Chief Technology Officer, Dr.&nbsp;Solomon also navigated numerous complex intellectual property and technology issues associated
with Agilent&rsquo;s multiple separation and acquisition transactions. Dr.&nbsp;Solomon is currently an independent director on the boards
of Materion Corporation (NYSE: MTRN), where she is a past member of the Audit and Risk Committee and currently a member of the Compensation
Committee and the Nominating, Governance, and Corporate Responsibility Committee, and of Novanta Inc. (NASDAQ: NOVT), where she is a
member of the Compensation Committee. Dr.&nbsp;Solomon was the Senior Vice President and Chief Technology Officer of Agilent Technologies,&nbsp;Inc.
(operating in the life sciences, diagnostics and applied chemical markets) until July&nbsp;2023. Dr.&nbsp;Solomon previously served in
a number of leadership positions, including as Vice President and Director of Agilent Laboratories, Agilent&rsquo;s centralized advanced
research organization, and in a dual capacity as the Director of the Life Sciences Technologies Laboratory and the Senior Director, Research
and Development/Technology of Agilent&rsquo;s Life Sciences and Chemical Analysis business. Dr.&nbsp;Solomon holds a bachelor&rsquo;s
degree in Chemistry from Stanford University and a Ph.D. in Inorganic Chemistry from MIT. Dr.&nbsp;Solomon is also a member of the National
Academy of Engineering and serves on multiple academic and government advisory boards focused on science, technology, and innovation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">We believe that Dr.&nbsp;Solomon&rsquo;s
extensive knowledge and experience in company separations, markets important to the Company and intellectual property as well as having
recently led innovation in a diversified global technology enterprise, would bring to the Board valuable insight on research and development,
strategy, intellectual property, sustainability and the operational challenges faced by companies focused on commercialization of technology
innovations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">As of the date hereof, Dr.&nbsp;Solomon
does not own any securities of the Company and has not entered into any transactions in the securities of the Company during the past
two years. The principal business address of Dr.&nbsp;Solomon is 17 Valley Oak, Portola Valley, CA 94028.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Other than as stated herein,
there are no arrangements or understandings among the members of Politan or any other person or persons pursuant to which the nomination
of the Politan Nominees described herein is to be made, other than the consent by each of the Politan Nominees to be named as a nominee
of Politan in any proxy statement relating to the 2024 Annual Meeting and serving as a director of the Company if elected as such at
the 2024 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Interests in the Solicitation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Politan Nominees may be
deemed to have an interest in their nominations for election to the Board by virtue of the compensation that the Politan Nominees will
receive from the Company as a director, if elected to the Board, and as described below. We expect that the Politan Nominees, if elected,
will be indemnified for their service as directors of the Company to the same extent indemnification is provided to the current directors
of the Company under the Bylaws and the Company&rsquo;s Amended and Restated Certificate of Incorporation and be covered by the policy
of insurance which insures the Company&rsquo;s directors and officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Mr.&nbsp;Koffey could be considered
to have an indirect interest in this Proposal One (Election of the Politan Nominees as Directors), as described in further detail below.
Other than as set forth in this Proxy Statement and in Schedule I (which is incorporated herein by reference), no Participant, or any
associate of any Participant, has any substantial interest, direct or indirect, by security holdings or otherwise, in any matter to be
acted upon at the 2024 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Mr.&nbsp;Koffey is the Managing
Partner and Chief Investment Officer of Politan which serves as the investment advisor to the Politan Funds. Mr.&nbsp;Koffey is also
the Managing Member of Politan Management and Politan GP. Through these roles, Mr.&nbsp;Koffey controls the investment and voting decisions
of the Politan Funds with respect to any securities held by the Politan Funds, including any interests in Common Stock held by the Politan
Funds. Politan GP is entitled to an incentive allocation from Politan Master Fund, which is customary in the investment management industry
and is based on a percentage of the increase or decrease in the value of the investment portfolio of the Politan Funds, of which interests
in Common Stock form a part as of the date hereof. Politan is also entitled to a management fee based on a percentage of the total value
of the investment portfolio from Politan Offshore and Politan LP. Mr.&nbsp;Koffey is entitled to portions of such payments through his
direct or indirect equity interests in the applicable Politan Parties, including limited partnership interests in Politan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Arrangements between Politan and the Politan Nominees</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Politan has entered into Engagement
and Indemnification Agreements with each of the Politan Nominees, dated as of March&nbsp;22, 2024 (collectively, the &ldquo;<U>Engagement
and Indemnification Agreements</U>&rdquo;), pursuant to which it has agreed to indemnify each Politan Nominee against claims arising
from the solicitation of proxies from the Stockholders in connection with the 2024 Annual Meeting and any related transactions. For the
avoidance of doubt, this indemnification obligation does not apply or extend to any claims made against either Politan Nominee in his
or her capacity or service as a director of the Company, if so elected. Pursuant to their Engagement and Indemnification Agreement, each
Politan Nominee has agreed to, among other matters, stand as a Politan Nominee of the Record Stockholder for election to the Board at
the 2024 Annual Meeting, be named in Politan&rsquo;s solicitation materials, serve as a director if elected and coordinate with Politan
in connection with any public disclosures or litigation relating to the solicitation. Pursuant to their Engagement and Indemnification
Agreement, each Politan Nominee received a $50,000 payment upon execution of his or her respective Engagement and Indemnification Agreement,
with a further $50,000 payable upon the earlier to occur of (i)&nbsp;such Politan Nominee&rsquo;s election to the Board by the Stockholders
or appointment to the Board pursuant to an agreement between the Company and Politan, or (ii)&nbsp;such Politan Nominee not being elected
as a director of the Company following the conclusion of a proxy solicitation in which Politan nominated (and did not withdraw) his or
her nomination for election to the Board. Politan has agreed to indemnify each Politan Nominee against any losses suffered, incurred
or sustained by such Politan Nominee in connection with such Politan Nominee being a member of the slate or the solicitation of proxies
in connection therewith. Politan has further agreed to reimburse each Politan Nominee for reasonable, documented, out-of-pocket expenses
incurred as a result of such Politan Nominee being a member of the slate, including, without limitation, travel expenses and expenses
in connection with legal counsel retained to represent each Politan Nominee in connection with being a member of the slate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Each Politan Nominee also executed
a written consent to serve as a director if elected. The foregoing description is qualified in its entirety by reference to the form
of Engagement and Indemnification Agreement attached as Exhibit&nbsp;99.9 to Amendment No.&nbsp;7 to Schedule 13D filed by Politan with
respect to the Company on March&nbsp;27, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Compensation of the Company&rsquo;s Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">If elected to the Board, the
Politan Nominees will not receive any compensation from the Politan Parties to serve as a director. The Politan Parties expect, however,
that the Politan Nominees, if elected, will receive whatever compensation the Board has established for non-employee directors of the
Company, unless and until the Board determines to change such compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">As disclosed in the Company
Proxy Statement, non-employee directors of the Company were entitled to receive the following compensation in the 2023 fiscal year:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Board
                                            retainer: $70,000 annually;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Audit
                                            Committee Chairperson retainer: $25,000 annually;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Audit
                                            Committee member retainer: $12,500 annually;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Compensation
                                            Committee Chairperson retainer: $20,000 annually;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Compensation
                                            Committee member retainer: $10,000 annually;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Nominating
                                            Committee Chairperson retainer: $15,000 annually; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Nominating
                                            Committee member retainer: $5,000 annually.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">In addition, according to the
Company Proxy Statement, each non-employee director is granted an award of RSUs with respect to shares of Common Stock having a grant
date fair value of $200,000, rounded down to the nearest whole share, which will vest on the earlier of the first anniversary of the
grant date or the date of the next annual meeting of Stockholders. RSUs granted to non-employee directors also vest in full in the event
of a change in control of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Under the Employment Agreement,
Mr.&nbsp;Kiani generally may assert &ldquo;Good Reason&rdquo; to terminate his employment&mdash;and thereby trigger entitlement to the
severance benefits available thereunder&mdash;if he ceases to serve as Chairman of the Board. Accordingly, if the Politan Nominees are
elected and, as a result, Mr.&nbsp;Kiani ceases to be a director, he necessarily would cease to be the Board&rsquo;s Chairman, and he
would then be in a position to terminate his employment and claim it was for Good Reason, as defined in the Employment Agreement. To
do so, however, Mr.&nbsp;Kiani must first notify the Company of his intent to terminate his employment for Good Reason, and the Company
then has thirty (30) days to &ldquo;cure&rdquo; those circumstances&mdash;for example, here, by reinstating Mr.&nbsp;Kiani as Chairman.
To effect that particular cure, the Company could, among other things, expand the size of the Board and invite Mr.&nbsp;Kiani to serve
as its Chairman; as a result, Mr.&nbsp;Kiani&rsquo;s ceasing to be a member of the Board (and its Chairman) would not necessarily result
in his ability to terminate his employment for Good Reason under the Employment Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Politan Parties believe
that the director change of control provisions in the Employment Agreement are unenforceable. Further, if Mr.&nbsp;Kiani is not reelected
at the 2024 Annual Meeting, the Politan Parties believe that offering to reappoint Mr.&nbsp;Kiani to the Board as Chairman within thirty
(30) days would satisfy the cure provisions in the Employment Agreement, regardless of whether he accepts the offer. According to the
Company Proxy Statement, it is Mr.&nbsp;Kiani&rsquo;s interpretation of the Employment Agreement that if he is not re-elected to the
Board, declines re-appointment to the Board and terminates his employment with the Company for &ldquo;Good Reason&rdquo; under the Employment
Agreement, he would be entitled to a payment of an amount equal to his full base salary through the date of termination, if applicable,
and an additional amount equal to twice the sum of his base salary then in effect and the average annual bonus paid to him over the prior
three years, which would be paid in installments over two years pursuant to the Company&rsquo;s normal payroll practices; and all of
his outstanding options and other equity awards would immediately vest. In addition, according to the Company Proxy Statement, 2.7 million
shares of Common Stock subject to an RSU award previously granted to Mr.&nbsp;Kiani under the Employment Agreement would vest in full
and the Company would be required to pay him a cash amount equal to $35 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">For a representative quantification
of estimated payments due if Mr.&nbsp;Kiani is not re-elected to the Board and his interpretation of the Employment Agreement prevails,
please refer to page&nbsp;36 of the Company Proxy Statement. The Company Proxy Statement also discloses additional information with respect
to the Employment Agreement in the section titled &ldquo;Executive Compensation-Employment Arrangements with Named Executive Officers-Employment
Agreement with Mr.&nbsp;Kiani.&rdquo; The Employment Agreement is disclosed along with amendments thereto as exhibits 10.2, 10.3 and
10.4 of the Company&rsquo;s 2023 Annual Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">To be clear, the Politan Parties
do not intend for this proxy solicitation to be about firing Mr.&nbsp;Kiani. On several occasions, including in the Response to the May&nbsp;9
Proposal, the Politan Parties have extended an offer that Mr.&nbsp;Kiani remain on the Board if both of the Politan Nominees are also
added to the Board&mdash;something that the incumbent Board has so far been unwilling to do. If the Politan Nominees are elected, then
together with the 2023 Newly-Elected Directors, such truly independent directors will constitute a majority of the Board, even if Mr.&nbsp;Kiani
is added back to the Board as a director. While Mr.&nbsp;Koffey holds senior positions at Politan, Ms.&nbsp;Brennan, Mr.&nbsp;Jellison
and Dr.&nbsp;Solomon are independent of Politan. If the Politan Nominees are elected at the 2024 Annual Meeting, the Politan Parties
would support the Board extending an offer to Mr.&nbsp;Kiani to rejoin the Board as Chairman.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Politan believes that the decision
regarding who should serve as the Company&rsquo;s chief executive officer is one that the Board should make following the conclusion
of the proxy contest with the information then available to the Board. To date, Politan has had significant concerns about the performance,
management and governance of the Company under Mr.&nbsp;Kiani&rsquo;s leadership and a Board composed of a majority of his hand-picked
directors. To the extent that Mr.&nbsp;Kiani is able and willing to reasonably address the foregoing concerns, Politan remains open minded
as to how Mr.&nbsp;Kiani may perform as the Company&rsquo;s chief executive officer under the supervision of, and potentially as a member
of, a Board consisting of a majority of truly independent directors. Furthermore, the Politan Nominees have made no decisions regarding
whether Mr.&nbsp;Kiani should remain the Company&rsquo;s chief executive officer following the proxy contest should they be elected to
the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Politan Parties understand
that the Company maintains, at its expense, a policy of insurance which insures its directors and officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Bylaws also contain provisions
that, among other matters, provide for the indemnification of officers and directors to the fullest extent permitted by Delaware law.
The Politan Parties expect that the Politan Nominees, if elected, will be indemnified in connection with his or her service as a director
of the Company to the same extent as the current directors of the Company under the Bylaws and will be covered by the policy of insurance
which insures the Company&rsquo;s directors and officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The share ownership level of
each current non-employee director and the compensation that each non-employee director of the Company was entitled to receive during
the fiscal year ended December&nbsp;30, 2023 is set forth in the Company Proxy Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">None of the Politan Nominees
or any of their respective associates has received any cash compensation, cash bonuses, deferred compensation, compensation pursuant
to plans, or other compensation, from, or in respect of, services rendered on behalf of the Company that is required to be disclosed
under, or is subject to any arrangement described in Item 402 of Regulation S-K promulgated under the Exchange Act (&ldquo;<U>Regulation
S-K</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Neither of the Politan Nominees
has any position or office with the Company, and no occupation or employment in which the Politan Nominees have been involved during
the past five years was carried on with the Company or any company or organization that is a parent, subsidiary or other affiliate of
the Company, and neither of the Politan Nominees has ever served on the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Politan Parties believe
that each of the Politan Nominees, if elected as a director of the Company, would be an &ldquo;independent director&rdquo; within the
meaning of applicable Nasdaq listing standards applicable to board composition, including Rule&nbsp;5605(a)(2), and Section&nbsp;301
of the Sarbanes-Oxley Act of 2002. Notwithstanding the foregoing, the Politan Parties acknowledge that no director of a Nasdaq listed
company qualifies as &ldquo;independent&rdquo; under the Nasdaq listing standards unless the board of directors of such company affirmatively
determines that such director is independent under such standards. Accordingly, the Politan Parties acknowledge that if any Politan Nominee
is elected, the determination of such Politan Nominee&rsquo;s independence under the Nasdaq listing standards ultimately rests with the
judgment and discretion of the Board. If elected, we believe that each Politan Nominee would qualify as an independent member of the
Company&rsquo;s Compensation Committee, Nominating Committee and Audit Committee under each such committee&rsquo;s applicable independence
standards. In addition, each Politan Nominee understands that, if elected as a director of the Company, such Politan Nominee would have
an obligation to act in the best interests of the Company and the Stockholders in accordance with his or her duties as a director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Except as set forth in this
Proxy Statement (including <I>Annex A </I>and the Schedules hereto), (i)&nbsp;no Politan Nominee has a family relationship with any director,
executive officer, or person nominated or chosen by the Company to become a director or executive officer, and (ii)&nbsp;with respect
to each of the Politan Nominees, none of the events enumerated in Item 401(f)(1)-(8)&nbsp;of Regulation S-K of the Exchange Act occurred
during the past 10 years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The information herein regarding
each Politan Nominee has been furnished to us by such Politan Nominee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">We expect that the Politan
Nominees will be able to stand for election, but, in the event any Politan Nominee is unable to serve or for good cause will not serve,
the shares of Common Stock represented by the enclosed <B>updated WHITE universal proxy card or voting instruction form</B> will be voted
for substitute nominee(s), to the extent this is not prohibited under the Bylaws and applicable law. In addition, we reserve the right
to nominate substitute person(s)&nbsp;if the Company makes or announces any changes to the Bylaws or takes or announces any other action
that has, or if consummated would have, the effect of disqualifying a Politan Nominee, to the extent this is not prohibited under the
Bylaws and applicable law. In any such case, we would identify and properly nominate such substitute nominee(s)&nbsp;in accordance with
the Bylaws and the shares of Common Stock represented by the enclosed <B>updated WHITE universal proxy card or voting instruction form
</B>will be voted for such substitute nominee(s). We reserve the right to nominate additional person(s), to the extent this is not prohibited
under the Bylaws and applicable law, if the Company increases the size of the Board above its existing size or increases the number of
directors whose terms expire at the 2024 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Politan Parties and Masimo
will each be using a universal proxy card for voting on the election of directors at the 2024 Annual Meeting, which will include the
names of all nominees for election to the Board. Each of the Politan Nominees has consented to being named as a nominee for election
as a director of the Company in any proxy statement relating to the 2024 Annual Meeting. Stockholders will have the ability to vote for
up to two nominees on the Politan Parties&rsquo; enclosed <B>updated WHITE universal proxy card or voting instruction form</B>. There
is no need to use the Company&rsquo;s gold proxy card or voting instruction form, regardless of how you wish to vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Stockholders are permitted
to vote for less than two nominees or for any combination OF up to two OF the Politan Nominees and the Company&rsquo;s nominees on the
<B>updated WHITE universal proxy card or voting instruction form</B>. IMPORTANTLY,&nbsp;IF YOU MARK MORE THAN TWO &ldquo;FOR&rdquo; BOXES
WITH RESPECT TO THE ELECTION OF DIRECTORS, ALL OF YOUR VOTES FOR THE ELECTION OF DIRECTORS WILL BE DEEMED INVALID.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>WE STRONGLY URGE YOU TO
VOTE ON THE ENCLOSED UPDATED WHITE UNIVERSAL PROXY CARD OR VOTING INSTRUCTION FORM&nbsp;&ldquo;FOR&rdquo; THE ELECTION OF THE POLITAN
NOMINEES AND VOTE TO &ldquo;WITHHOLD&rdquo; ON THE ELECTION OF THE COMPANY&rsquo;S NOMINEES.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Proposal
Two</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RATIFICATION OF THE SELECTION OF GRANT THORNTON
LLP<BR>
AS THE COMPANY&rsquo;S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM<BR>
FOR THE FISCAL YEAR ENDING DECEMBER 28, 2024</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">According to the Company Proxy
Statement, the Audit Committee has selected Grant Thornton LLP (&ldquo;<U>Grant Thornton</U>&rdquo;) as its independent registered public
accounting firm for the fiscal year ending December&nbsp;28, 2024, and has further directed that management submit the selection of the
Company&rsquo;s independent registered public accounting firm for ratification by the Stockholders at the 2024 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">According to the Company Proxy
Statement, Grant Thornton was appointed as the Company&rsquo;s independent registered public accounting firm in July&nbsp;2006 and has
reported on its consolidated financial statements for years 2005 through 2023. The Company Proxy Statement states that the decision to
select Grant Thornton as the Company&rsquo;s independent registered public accounting firm for fiscal year 2024 (ending December&nbsp;28,
2024) was recommended by the Audit Committee and recommended by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">According to the Company Proxy
Statement, representatives of Grant Thornton are expected to be present at the 2024 Annual Meeting and will be able to make a statement
at the 2024 Annual Meeting if they wish and will be available to respond to appropriate questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Neither the Bylaws nor other
governing documents or law require that the Stockholders ratify the selection of Grant Thornton as the Company&rsquo;s independent registered
public accounting firm. According to the Company Proxy Statement, the Audit Committee has directed that management submit the selection
of Grant Thornton to the Stockholders for ratification by Stockholders at the 2024 Annual Meeting as a matter of good corporate practice.
If the Stockholders fail to ratify the selection, the Audit Committee will reconsider whether or not to retain that firm. Even if the
selection is ratified, the Audit Committee in its discretion may direct the appointment of different independent registered public accounting
firms at any time during the year if it determines that such a change would be in the best interests of the Company and the Stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">As the Company has submitted
the ratification of its registered public accounting firm for approval by the Stockholders, according to the Company Proxy Statement,
the number of votes cast &ldquo;FOR&rdquo; the proposal must exceed the number of votes cast &ldquo;AGAINST&rdquo; such proposal to ratify
the selection of Grant Thornton as the Company&rsquo;s independent registered public accounting firm for the fiscal year ending December&nbsp;28,
2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WE RECOMMEND A VOTE &ldquo;FOR&rdquo; THIS
PROPOSAL.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Proposal
Three</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B>A</B></FONT><B>DVISORY
VOTE TO APPROVE<BR>
THE COMPENSATION OF NAMED EXECUTIVE OFFICERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">According to the Company Proxy
Statement, the Board requests that the Stockholders approve the compensation of its Named Executive Officers (as described in the Company
Proxy Statement) pursuant to Section&nbsp;14A of the Exchange Act. A discussion of this matter can be found in the Company Proxy Statement
in the section titled &ldquo;<I>Compensation Discussion and Analysis</I>&rdquo; beginning on page&nbsp;55 of the Company Proxy Statement,
and the compensation tables beginning on page&nbsp;79 of the Company Proxy Statement, and any related narrative discussion contained
throughout the Company Proxy Statement.<B><I>&nbsp;</I></B>This vote is advisory and not binding on the Company, but the Company Proxy
Statement states that the Board and the Compensation Committee value the opinions of the Stockholders and will consider the outcome of
the vote in determining its executive compensation program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&ldquo;Say-on-Pay&rdquo; Vote</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Company Proxy Statement
provides that the Board maintains a pay for performance philosophy that forms the foundation for all of the Compensation Committee&rsquo;s
decisions regarding executive compensation. The Company Proxy Statement states that its compensation program is designed to facilitate
strong corporate governance, foster collaboration and support the Company&rsquo;s short and long-term strategy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Company Proxy Statement
provides that further information regarding the Company&rsquo;s executive compensation can be found in the <I>Compensation Discussion
and Analysis</I> portion of the Company Proxy Statement, which contains a detailed description of the Company&rsquo;s executive compensation
philosophy and program, including the compensation decisions the Compensation Committee has made under the program and the factors considered
in making those decisions. The Company Proxy Statement discloses that Stockholders affirmed their support of the Company&rsquo;s program
in our outreach discussions and in recent Say-on-Pay annual vote results. The Company Proxy Statement expresses the Company&rsquo;s belief
that it has created a compensation program deserving of the Stockholder support and that the compensation of the Company&rsquo;s named
executive officers for fiscal year 2023 was appropriate and reasonable, as well as reflective of the Company&rsquo;s performance for
the year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Accordingly, the Company Proxy
Statement states that the following resolution is submitted for a Stockholder vote at the 2024 Annual Meeting:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;<I>RESOLVED</I>, that the stockholders
of Masimo Corporation approve, on an advisory basis, our named executive officer compensation for fiscal 2023, as disclosed pursuant
to Item&nbsp;402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and related narrative discussion,
in this Proxy Statement.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="background-color: white">The
Company Proxy Statement states that the Stockholder vote on named executive officer compensation is merely advisory and will not be binding
upon the Company, the Board or the Compensation Committee, and that the outcome of the vote will not require the Company, the Board or
the Compensation Committee to take any action or overrule&nbsp;any decision by the Company, the Board or the Compensation Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Politan Parties do not
believe that the Company&rsquo;s performance justifies the executive officer compensation disclosed in the Company Proxy Statement. As
the Company Proxy Statement discloses, &ldquo;2023 financial performance fell below the objective performance goals established under
[its] compensation program.&rdquo; The Company&rsquo;s stock price in October&nbsp;2023 reached a five year low and remains as of June&nbsp;2024
more than 40% below the valuation it reached in February&nbsp;2022, immediately prior to the announcement of the acquisition of Sound
United.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Furthermore, the advisory vote
with respect to named executive officer compensation at the 2023 Annual Meeting only narrowly passed, and the Politan Parties do not
believe that enough was subsequently done to address Stockholder concerns in this regard. Finally, as discussed in the &ldquo;<FONT STYLE="text-transform: uppercase">Background
of the Solicitation</FONT>,&rdquo; the Politan Parties believe that the Company&rsquo;s management, including the Chief Executive Officer,
has repeatedly obstructed the adoption of effective corporate governance practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>WE RECOMMEND A VOTE &ldquo;AGAINST&rdquo;
THIS PROPOSAL AND INTEND TO VOTE OUR POLITAN SHARES &ldquo;AGAINST&rdquo; THIS PROPOSAL.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Proposal
Four</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>POLITAN PARTIES PROPOSAL TO REPEAL<BR>
ANY PROVISION OF, OR AMENDMENT TO, THE BYLAWS ADOPTED<BR>
BY THE BOARD WITHOUT STOCKHOLDER APPROVAL<BR>
SUBSEQUENT TO APRIL 20, 2023 AND UP TO AND INCLUDING<BR>
THE DATE OF THE 2024 ANNUAL MEETING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">We have notified the Company
that we intend to present the Bylaw Proposal for consideration at the 2024 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Politan Parties believe
that in order to ensure that the will of the Stockholders with respect to this proxy solicitation is upheld, no effect should be given
to any provision of, or amendment to, the Bylaws unilaterally adopted by the Board after the date of the most recent publicly disclosed
Bylaws, which is April&nbsp;20, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Stockholders are therefore
being asked to adopt a resolution that would repeal any provision of the Bylaws or amendment to the Bylaws that the Board adopted or
adopts without the approval of the Stockholders after April&nbsp;20, 2023 and up to and including the date of the 2024 Annual Meeting,
including, without limitation, any amendments that the Board has adopted without public disclosure, or that the Board might adopt in
an effort to: impede the effectiveness of the Record Stockholder&rsquo;s nomination of the Politan Nominees, negatively impact the Politan
Parties&rsquo; ability to solicit and/or obtain proxies from Stockholders, contravene the will of the Stockholders expressed in those
proxies, or modify the Company&rsquo;s corporate governance regime.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Accordingly, the following
resolution will be submitted for a Stockholder vote at the 2024 Annual Meeting and we strongly urge that Stockholders for &ldquo;<B>FOR</B>&rdquo;
this resolution:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&ldquo;RESOLVED,
</I></FONT>that each provision of, or amendment to, the Bylaws adopted by the Board without the approval of the stockholders of the Company
subsequent to April&nbsp;20, 2023 (the date of the most recent publicly disclosed Bylaws) and up to and including the date of this meeting
of stockholders at which this resolution is being proposed, be, and hereby is, repealed, effective as of the time this resolution is
approved by the Company&rsquo;s stockholders.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Company Proxy Statement
states that the adoption of the Bylaw Proposal will require the affirmative vote of the holders of at least seventy-five percent (75%)
of the voting power of all of the then-outstanding shares of Common Stock entitled to vote generally in the election of directors, voting
together as a single class.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>WE STRONGLY URGE YOU TO
VOTE &ldquo;FOR&rdquo; THE APPROVAL OF THE BYLAW PROPOSAL ON THE ENCLOSED UPDATED WHITE UNIVERSAL PROXY CARD OR VOTING INSTRUCTION FORM.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>No
Appraisal or Dissenter&rsquo;s Rights</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Stockholders will not have
rights of appraisal or similar dissenter&rsquo;s rights with respect to any matters identified in this Proxy Statement to be acted upon
at the 2024 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Voting
and Proxy Procedures</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Only Stockholders of record
at the close of business on the Record Date will be entitled to notice of and to vote at the 2024 Annual Meeting. Each share of Common
Stock is entitled to one vote. Stockholders who sell shares of Common Stock before the Record Date (or acquire them without voting rights
after the Record Date) may not vote such shares of Common Stock. Stockholders of record on the Record Date will retain their voting rights
in connection with the 2024 Annual Meeting even if they sell such shares of Common Stock after the Record Date. Based on publicly available
information, we believe that the only outstanding class of securities of the Company entitled to vote at the 2024 Annual Meeting is the
Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Shares of Common Stock represented
by properly executed <B>updated WHITE universal proxy card or voting instruction form</B> will be voted at the 2024 Annual Meeting as
marked and, in the absence of specific instructions, will be voted (1)&nbsp;&ldquo;<B>FOR&rdquo;</B> the election of the Politan Nominees
to the Board, (2)&nbsp;&ldquo;<B>FOR&rdquo; </B>the ratification of Grant Thornton LLP as the Company&rsquo;s independent registered
public accounting firm for the 2024 fiscal year, (3)&nbsp;&ldquo;<B>AGAINST&rdquo;</B> the approval of named executive officer compensation,
and (4)&nbsp;&ldquo;<B>FOR&rdquo;</B> the approval of the Bylaw Proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Politan Parties and Masimo
will each be using a universal proxy card for voting on the election of directors at the 2024 Annual Meeting, which will include the
names of all nominees for election to the Board. Stockholders will have the ability to vote for up to two nominees on the Politan Parties&rsquo;
enclosed <B>updated WHITE universal proxy card or voting instruction form</B>. <B>There is no need to use the Company&rsquo;s gold proxy
card or voting instruction form, regardless of how you wish to vote.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Company has a classified
Board, which is currently divided into three classes. The terms of the Class&nbsp;II director(s)&nbsp;expire at the 2024 Annual Meeting.
Through the attached Proxy Statement and enclosed <B>updated WHITE universal proxy card or voting instruction form</B>, we are soliciting
proxies to elect the two Politan Nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Stockholders are permitted
to vote for less than two nominees or for any combination (up to two total) of the Politan Nominees and the Company&rsquo;s nominees
on the <B>updated WHITE universal proxy card or voting instruction form</B>. The Politan Parties urge Stockholders to vote <B>&ldquo;FOR&rdquo;
</B>both of the Politan Nominees and vote to &ldquo;<B>WITHHOLD</B>&rdquo; on the Company&rsquo;s nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>IMPORTANTLY,&nbsp;IF YOU
MARK MORE THAN TWO &ldquo;FOR&rdquo; BOXES WITH RESPECT TO THE ELECTION OF DIRECTORS, ALL OF YOUR VOTES FOR THE ELECTION OF DIRECTORS
WILL BE DEEMED INVALID. IF YOU MARK ONLY ONE &ldquo;FOR&rdquo; BOX WITH RESPECT TO THE ELECTION OF DIRECTORS, YOUR SHARES WILL ONLY BE
VOTED &ldquo;FOR&rdquo; THE NOMINEE YOU HAVE SO MARKED.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">In the event that the Record
Stockholder withdraws its nomination of either of the Politan Nominees or abandons its solicitation, any votes cast in favor of the Politan
Nominees will be disregarded and not be counted, whether such vote is provided on the Company&rsquo;s gold universal proxy card or the
Politan Parties&rsquo; <B>updated WHITE universal proxy card or voting instruction form</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">With respect to votes cast
in favor of the Company&rsquo;s nominees or on matters other than the election of directors, in the event that the Record Stockholder
withdraws its nomination of either of the Politan Nominees or abandons its solicitation, the Politan Parties will still submit such votes
to the independent inspector.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">If you have previously voted
on the <B>WHITE universal proxy card or voting instruction form</B> for the annual meeting previously scheduled for July&nbsp;25, 2024,
your vote is no longer valid. To enable your votes to be validly counted for the 2024 Annual Meeting, you must resubmit your vote on
the <B>updated WHITE universal proxy card or voting instruction form</B> attached to this Proxy Statement for the 2024 Annual Meeting
now scheduled to be held on September&nbsp;19, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Quorum; Abstentions and Broker Non-Votes; No Discretionary Voting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">A quorum of Stockholders is
necessary to hold a valid meeting. The Company Proxy Statement states that <FONT STYLE="background-color: white">a </FONT>quorum will
be present if at least a majority of the voting power of all of the sha<FONT STYLE="background-color: white">res of Common </FONT>Stock
<FONT STYLE="background-color: white">are represented by votes at the 2024 Annual Meeting or by proxy. </FONT>The Company has not yet
publicly disclosed the number of shares of Common Stock outstanding as of the Record Date. Accordingly, we have omitted such information
from this Proxy Statement, and this information together with the number of votes that must <FONT STYLE="background-color: white">be
represented at the 2024 Annual Mee</FONT>ting or by proxy to have a quorum will be included in the Company Proxy Statement relating to
the 2024 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Company Proxy Statement
states that your shares will be counted towards the quorum only if you submit a valid proxy (or if one is submitted on your behalf by
your broker, bank or other agent) or if you vote at the 2024 Annual Meeting. If there is no quorum, the Company Proxy Statement states
that the chairman of the meeting or the Stockholders holding a majority of the shares present at the 2024 Annual Meeting will adjourn
the 2024 Annual Meeting to another date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">If you are a beneficial owner,
your broker will vote your shares pursuant to your instructions. A broker&rsquo;s inability to vote with respect to the non-discretionary
matters for which the broker has&nbsp;not&nbsp;received voting instructions from the beneficial owner is referred to as a &ldquo;broker
non-vote.&rdquo; The Company Proxy Statement states that, because the Politan Parties have initiated a proxy contest, to the extent the
Politan Parties provide a proxy card or voting instruction form to Stockholders who hold their shares in &ldquo;street name,&rdquo; brokers
will not have discretionary voting authority to vote on any of the proposals presented at the 2024 Annual Meeting, including the Ratification
of Auditors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Company Proxy Statement
states that abstentions and broker non-votes will be treated as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Abstentions:
</I></FONT>Under Delaware law (under which the Company is incorporated), abstentions are counted as shares present and entitled to vote
at the 2024 Annual Meeting, but they are not counted as shares cast. Therefore, abstentions will have no effect on <I>Proposal No.&nbsp;2&mdash;Ratification
of Auditors</I> or <I>Proposal No.&nbsp;3&mdash;Advisory Vote to Approve the Compensation of Named Executive Officers</I>. An abstention
will have the same effect as a vote &ldquo;<B>AGAINST</B>&rdquo; <I>Proposal No.&nbsp;4&mdash;the Politan Parties&rsquo; Proposal to
repeal any provision of, or amendment to, the Bylaws adopted by the Board without stockholder approval subsequent to April&nbsp;20, 2023
and up to and including the date of the 2024 Annual Meeting</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Broker
Non-Votes:</I></FONT> Brokers, banks and other such record holders are not permitted to vote the uninstructed shares of their customers
on a discretionary basis in the election of directors or on named executive officer compensation matters. Because broker non-votes are
not considered under Delaware law to be entitled to vote at the 2024 Annual Meeting, they will have no effect on the outcome of the vote
on: <I>Proposal No.&nbsp;1&mdash;Election of Directors</I> or <I>Proposal No.&nbsp;3&mdash;Advisory Vote to Approve the Compensation
of Named Executive Officers</I>. A broker non-vote will have the same effect as a vote &ldquo;<B>AGAINST</B>&rdquo; <I>Proposal No.&nbsp;4&mdash;the
Politan Parties&rsquo; Proposal to repeal any provision of, or amendment to, the Bylaws adopted by the Board without stockholder approval
subsequent to April&nbsp;20, 2023 and up to and including the date of the 2024 Annual Meeting</I>. As stated in the Company Proxy Statement,
because the Politan Parties have initiated a proxy contest, to the extent the Politan Parties provide a proxy card or voting instruction
form to Stockholders who hold their shares in &ldquo;street name,&rdquo; brokers will not have discretionary voting authority to vote
on any of the proposals presented at the 2024 Annual Meeting, including <I>Proposal No.&nbsp;2&mdash;Ratification of Auditors</I>. Broker
non-votes, if any, will have no effect on the outcome of the vote on <I>Proposal No.&nbsp;2&mdash;Ratification of Auditors</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Company Proxy Statement
states that if you hold your shares in street name and you do not instruct your broker, bank or other such holder how to vote your shares
in the election of directors, the advisory vote related to the approval of the Company&rsquo;s named executive officer executive compensation
program or the Bylaw Proposal, no votes will be cast on your behalf on these proposals. <B>Therefore, it is critical that you indicate
your vote on these proposals if you want your vote to be counted</B>. We encourage you to vote promptly, even if you plan on attending
the 2024 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Votes Required for Approval</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>What vote is required to elect the Politan Nominees?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Company Proxy Statement
states that according to the Bylaws, in a contested election such as this one, directors shall be elected on a plurality basis. A &ldquo;plurality
cast&rdquo;, with regard to the election of a director, means that the two (2)&nbsp;director nominees receiving the greatest number of
votes cast &ldquo;for&rdquo; their election will be elected. Votes withheld and broker non-votes are not votes cast and will result in
the applicable nominees receiving fewer &ldquo;FOR&rdquo; votes for purposes of determining the two director nominees receiving the most
votes. A properly executed proxy marked to &ldquo;WITHHOLD&rdquo; a vote with respect to the election of any or all director nominees
will be counted for purposes of determining whether there is a quorum, but will not be considered to have been voted for or against such
nominee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>How many shares of Common Stock must be voted in favor of the
other proposals described in this Proxy Statement?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The approval of the Bylaw Proposal
will require the affirmative vote of the holders of at least seventy-five percent (75%)&nbsp;of the voting power of all of the then-outstanding
shares of the capital stock of the Company entitled to vote generally in the election of directors. You may vote &ldquo;FOR&rdquo; or
 &ldquo;AGAINST&rdquo; or you may abstain on this proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">The
approval of <I>Proposal No.&nbsp;2 &ndash; Ratification of Auditors</I> and <I>Proposal No.&nbsp;3 &ndash; Advisory Vote to Approve the
Compensation of Named Executive Officers</I>, will each require the affirmative vote of the holders of a majority of the votes cast (disregarding
abstentions and broker non-votes), meaning the number of votes cast &ldquo;for&rdquo; the proposal must exceed the number of votes cast
 &ldquo;against&rdquo; such proposal</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">If other matters are properly
brought before the 2024 Annual Meeting, the vote required will be determined in accordance with applicable law, the listing standards
and rules&nbsp;of Nasdaq, the Company&rsquo;s Amended and Restated Certificate of Incorporation and the Bylaws, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>What should I do in order to vote for the Politan Nominees?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">If your shares of Common Stock
are held of record in your own name, please authorize a proxy to vote by marking, signing, dating and returning the enclosed <B>updated
<I>WHITE </I>proxy card </B>in the postage-paid envelope provided or by instructing us by telephone or via the Internet as to how you
would like your shares of Common Stock voted (instructions are on your updated <B><I>WHITE </I></B>proxy card).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">If you hold your shares of
Common Stock in &ldquo;street name&rdquo; with a bank, brokerage firm, dealer, trust company or other institution or nominee, only they
can exercise your right to vote with respect to your shares of Common Stock and only upon receipt of your specific instructions. Accordingly,
it is critical that you promptly give instructions to your bank, brokerage firm, dealer, trust company or other institution or nominee
to ensure that a <B>updated <I>WHITE </I>voting instruction form </B>is submitted on your behalf. Please follow the instructions to authorize
a proxy to vote provided on the enclosed updated <B><I>WHITE </I></B>voting instruction form. If your bank, brokerage firm, dealer, trust
company or other nominee provides for voting instructions to be delivered to them by Internet or telephone, instructions will be included
on the enclosed <B>updated <I>WHITE </I>voting instruction form</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">YOUR VOTE IS VERY IMPORTANT.
If you do not plan to attend the 2024 Annual Meeting, we encourage you to read this Proxy Statement and date, sign and return your completed
<B>updated <I>WHITE </I>proxy card or voting instruction</B> form prior to the 2024 Annual Meeting so that your shares of Common Stock
will be represented and voted in accordance with your instructions. Even if you plan to attend the 2024 Annual Meeting, we recommend
that you authorize a proxy to vote your shares of Common Stock in advance as described above to ensure that your vote will be counted
if you later decide not to attend the 2024 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">If you sign and submit your
<B>updated WHITE universal proxy card or voting instruction form</B> without specifying how you would like your shares voted, your shares
will be voted as specified above and in accordance with the discretion of the persons named on the <B>updated WHITE universal proxy card
or voting instruction form</B> with respect to any other matters that may be voted upon at the 2024 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">If you have previously voted
on the <B>WHITE universal proxy card or voting instruction form</B> for the annual meeting previously scheduled for July&nbsp;25, 2024,
your vote is no longer valid. To enable your votes to be validly counted for the 2024 Annual Meeting, you must resubmit your vote on
the <B>updated WHITE universal proxy card or voting instruction form</B> attached to this Proxy Statement for the 2024 Annual Meeting
now scheduled to be held on September&nbsp;19, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Revocation of Proxies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Stockholders may revoke their
proxies at any time prior to exercise by attending the 2024 Annual Meeting and voting in person (although attendance at the 2024 Annual
Meeting will not in and of itself constitute revocation of a proxy), by delivering a written notice of revocation, or by signing and
delivering a subsequently dated proxy which is properly completed. The latest dated proxy is the only one that will be counted. The revocation
may be delivered either to Politan in care of D.F. King at the address set forth on the back cover of this Proxy Statement or to the
Company at 52 Discovery,&nbsp;Irvine, California 92618, or any other address provided by the Company. Although a revocation is effective
if delivered to the Company, Politan requests that either the original or photostatic copies of all revocations be mailed to Politan
in care of D.F. King at the address set forth on the back cover of this Proxy Statement so that we will be aware of all revocations and
can more accurately determine if and when proxies have been received from the holders of record on the Record Date. Additionally, D.F.
King may use this information to contact Stockholders who have revoked their proxies in order to solicit later dated proxies for the
election of the Politan Nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>IF YOU WISH TO VOTE FOR THE POLITAN NOMINEES,
PLEASE SIGN, DATE AND RETURN THE ENCLOSED WHITE UNIVERSAL PROXY CARD OR VOTING INSTRUCTION FORM&nbsp;TODAY IN THE POSTAGE-PAID ENVELOPE
PROVIDED.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>If you have previously voted on the WHITE universal
proxy card or voting instruction form for the annual meeting previously scheduled for July&nbsp;25, 2024, your vote is no longer valid.
To enable your votes to be validly counted for the 2024 Annual Meeting, you must resubmit your vote on the updated WHITE universal proxy
card or voting instruction form attached to this Proxy Statement for the 2024 Annual Meeting now scheduled to be held on September&nbsp;19,
2024.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Solicitation
of Proxies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The solicitation of proxies
pursuant to this Proxy Statement is being made by the Participants. Proxies may be solicited by mail, facsimile, telephone,&nbsp;Internet,
in person and by advertisements. Solicitations may be made by certain of the respective directors, officers, members and employees of
Politan, none of whom will, except as described elsewhere in this Proxy Statement, receive additional compensation for such solicitation.
The Politan Nominees may make solicitations of proxies but, except as described herein, will not receive compensation for acting as director
nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Politan has retained D.F. King
to provide solicitation and advisory services in connection with the 2024 Annual Meeting. Compensation terms of this engagement of the
proxy solicitor include $100,000 upon execution of the agreement, $125,000 upon Politan&rsquo;s mailing of a definitive proxy statement
to the Stockholders, and $125,000 upon the occurrence of the 2024 Annual Meeting. D.F. King also is entitled to reimbursement of reasonable
expenses incurred in connection with its delivery of services to Politan in connection with the solicitation. The terms of the engagement
provide further that Politan may, in its discretion, agree to pay an additional success fee to D.F. King in an amount to be determined
by Politan, in its sole discretion, if Politan determines that such a success fee is warranted in light of the performance by D.F. King
of its services. If paid, any such success fee would be a reasonable amount, which we presently anticipate would be equal to or lower
than 150% of the contractually required total amount of $350,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Politan agreed to indemnify
D.F. King against certain liabilities and expenses that it may incur in connection with delivery of services to Politan in connection
with the solicitation. As of the date hereof, the cost of retaining D.F. King is $250,000, and as set forth above, the total anticipated
cost thereof is not yet determinable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Politan has requested banks,
brokerage houses and other custodians, nominees and fiduciaries to forward all solicitation materials to the beneficial owners of the
shares of Common Stock they hold of record. Politan will reimburse these record holders for their reasonable out-of-pocket expenses in
so doing. It is anticipated that D.F. King will employ approximately 25 persons to solicit Stockholders for the 2024 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The entire expense of soliciting
proxies is being borne by Politan. Costs of this solicitation of proxies are currently estimated to be approximately $2,200,000 through
the date hereof. Politan estimates that its total expenses in connection with this solicitation may be approximately $6,000,000. The
amounts set forth in the previous sentence do not include legal fees and other costs incurred by the Politan Parties in connection with
either the California Action or the 2024 Court of Chancery Action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Politan estimates that through
the date hereof, its expenses (including legal fees and other costs) incurred in connection with the California Action and the 2024 Court
of Chancery Action, each brought in July&nbsp;2024, are nominal but not yet determinable. The Politan Parties incurred attorneys&rsquo;
fees and expenses of at least $17,800,000 in connection with the 2022 Litigation. On November&nbsp;17, 2023, the Court of Chancery granted
the Politan Parties&rsquo; motion for an award of attorneys&rsquo; fees and expenses in such amount from the Corporation in connection
with the 2022 Court of Chancery Action. At the time of the filing of this Proxy Statement, it is too early in the California Action or
the 2024 Court of Chancery Action to accurately estimate the fees and costs associated with either action, but such fees and costs may
in the aggregate be material. Additional legal fees are being incurred on an ongoing basis in connection with the California Action and
the 2024 Court of Chancery Action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Politan intends to seek reimbursement
from the Company of all costs and expenses that the Politan Parties incur in connection with the California Action, the 2024 Court of
Chancery Action and the solicitation of proxies for the election of the Politan Nominees to the Board at the 2024 Annual Meeting. Politan
does not intend to submit the question of such reimbursement to a vote of security holders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Additional
Participant Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">As described herein, the Participants
in the proxy solicitation are comprised of the Politan Parties, William Jellison and Darlene Solomon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The principal business address
of the Politan Parties is 106 West 56th Street, 10th Floor, New York, New York 10019. The principal business address of Mr.&nbsp;Jellison
is 9946 W. Gull Lake Dr., Richland, Michigan 49083. The principal business address of Dr.&nbsp;Solomon is 17 Valley Oak, Portola Valley,
CA 94028.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The principal business of Politan
is to serve as investment advisor to certain affiliated funds, including the Politan Funds. The principal business of Politan Management
is to serve as the general partner of Politan. The principal business of Politan GP is to serve as the general partner of certain affiliated
funds, including the Politan Funds. The principal occupation of Mr.&nbsp;Koffey is to serve as the Managing Partner and Chief Investment
Officer of Politan and the Managing Member of Politan Management and Politan GP. The principal business of the Record Stockholder is
to invest in securities and serve as record holder of shares of companies in which the Politan Funds may invest. The principal business
of each of the Politan Funds and of Politan Ltd. is to invest in securities. The principal occupation of each of Matthew Hall and Aaron
Kapito is to serve as an investment analyst of Politan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Politan, as the investment
adviser to the Politan Funds, may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or
direct the disposition of) the Politan Group Shares and, therefore, Politan may be deemed to be the beneficial owner of all of the Politan
Group Shares. Of the Politan Group Shares beneficially owned by the Politan Funds, 1,000 shares of Common Stock are held by the Record
Stockholder in record name. The Politan Group Shares collectively represent approximately 8.9% of the outstanding shares of Common Stock
based on 53,182,247 shares of Common Stock outstanding as of June&nbsp;13, 2024, as reported in the Company Proxy Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Applicable percentage ownership
is based on 53,182,247 shares of Common Stock outstanding as of June&nbsp;13, 2024, adjusted as required by rules&nbsp;promulgated by
the SEC. These rules&nbsp;generally attribute beneficial ownership of securities to persons who possess sole or shared voting power or
investment power with respect to those securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">As the general partner of Politan,
Politan Management may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the
disposition of) all of the Politan Group Shares and, therefore, Politan Management may be deemed to be the beneficial owner of all of
the Politan Group Shares. As the general partner of the Politan Funds, Politan GP may be deemed to have the shared power to vote or to
direct the vote of (and the shared power to dispose or direct the disposition of) all of the Politan Group Shares, and therefore Politan
GP may be deemed to be the beneficial owner of all of the Politan Group Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">By virtue of Mr.&nbsp;Koffey&rsquo;s
position as the Managing Partner and Chief Investment Officer of Politan and as the Managing Member of Politan Management and Politan
GP, Mr.&nbsp;Koffey may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the
disposition of) all of the Politan Group Shares. By virtue of Mr.&nbsp;Koffey&rsquo;s position as a director on the Board, Mr.&nbsp;Koffey
was granted 1,228 RSUs on June&nbsp;26, 2023, which vested into the Koffey Shares on June&nbsp;26, 2024. Mr.&nbsp;Koffey may be deemed
to have the sole power to vote or direct the vote of all of the Koffey Shares. Therefore, Mr.&nbsp;Koffey may be deemed to be the beneficial
owner of all of the Politan Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Except as otherwise indicated
in this Proxy Statement, we believe that the securities of the Company owned by the Participants as described herein have the sole or
shared voting and investment power with respect to all shares of Common Stock that they beneficially own, subject to applicable community
property laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Mr.&nbsp;Koffey is entitled
to certain compensation in connection with his service as a director on the Board and on the Audit Committee consisting of approximately
$82,500 in cash retainers plus the grant date fair value of the RSUs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Except as otherwise indicated
in this Proxy Statement, the securities of the Company directly or indirectly owned by each of the Participants were purchased with the
capital of the Politan Funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Except as set forth in this
Proxy Statement (including <I>Annex A</I> and the Schedules hereto), (i)&nbsp;during the past 10 years, no Participant has been convicted
in a criminal proceeding (excluding traffic violations or similar misdemeanors); (ii)&nbsp;no Participant directly or indirectly beneficially
owns any securities of the Company; (iii)&nbsp;no Participant owns any securities of the Company which are owned of record but not beneficially;
(iv)&nbsp;no Participant has purchased or sold any securities of the Company during the past two years; (v)&nbsp;no part of the purchase
price or market value of the securities of the Company owned by any Participant is represented by funds borrowed or otherwise obtained
for the purpose of acquiring or holding such securities; (vi)&nbsp;no Participant is, or within the past year was, a party to any contract,
arrangements or understandings with any person with respect to any securities of the Company, including, but not limited to, joint ventures,
loan or option arrangements, puts or calls, guarantees against loss or guarantees of profit, division of losses or profits, or the giving
or withholding of proxies; (vii)&nbsp;no associate of any Participant owns beneficially, directly or indirectly, any securities of the
Company; (viii)&nbsp;no Participant owns beneficially, directly or indirectly, any securities of any parent or subsidiary of the Company;
(ix)&nbsp;no Participant or any of his, her or its associates was a party to any transaction, or series of similar transactions, since
the beginning of the Company&rsquo;s last fiscal year, or is a party to any currently proposed transaction, or series of similar transactions,
to which the Company or any of its subsidiaries was or is to be a party, in which the amount involved exceeds $120,000; (x)&nbsp;no Participant
or any of his, her or its associates has any arrangement or understanding with any person with respect to any future employment by the
Company or its affiliates, or with respect to any future transactions to which the Company or any of its affiliates will or may be a
party; and (xi)&nbsp;no Participant has a substantial interest, direct or indirect, by securities holdings or otherwise in any matter
to be acted on at the 2024 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Legal Proceedings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Other than as described in
the &ldquo;<FONT STYLE="text-transform: uppercase">Background of the Solicitation</FONT>&rdquo; section above, to the knowledge of the
Politan Parties there are no material legal proceedings to which any Participant, the Politan Parties, the Politan Nominees or any of
their respective associates are a party adverse to the Company or any of its subsidiaries, or any material legal proceedings in which
any of the Participants, the Politan Parties, the Politan Nominees or any of their respective associates have a material interest adverse
to the Company or any of its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Stockholder
Nominations<BR>
and Proxy Access</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Company Proxy Statement
provides the applicable deadlines relating to the nomination of director nominees and stockholder proposals under the advance notice
provisions of the Bylaws for the 2025 Annual Meeting, which are incorporated by reference herein. The Company Proxy Statement provides
the deadlines by which proposals of stockholders intended to be presented at the 2025 Annual Meeting outside the processes of, and pursuant
to, Rule&nbsp;14a-8 or &ldquo;proxy access&rdquo; (<I>i.e.</I>, the procedures for placing a stockholder&rsquo;s proposal or director
nominee in the Company&rsquo;s proxy materials) must be received by the Corporate Secretary in order to be timely. Such deadlines are
also incorporated by reference herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">To comply with the universal
proxy rules, Stockholders who intend to solicit proxies in support of director nominees other than the Company&rsquo;s nominees must
provide the requisite written notice to the Company in accordance with Rule&nbsp;14a-19 of the Exchange Act no later than July&nbsp;21,
2025, or if the date of the 2025 Annual Meeting changes by more than 30 calendar days from the date of the one-year anniversary of the
2024 Annual Meeting, then the requisite written notice to the Company must be provided by the later of 60 calendar days prior to the
date of the 2025 Annual Meeting or the 10th calendar day following the day on which public announcement of the date of the 2025 Annual
Meeting is first made by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Other
Matters<BR>
and Additional Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The SEC allows the &ldquo;incorporation
by reference&rdquo; of information into this Proxy Statement, which allows the disclosure of important information to you by referring
you to another document filed separately with the SEC. The information incorporated by reference is considered to be part of this Proxy
Statement, except to the extent that the information is superseded by information in this Proxy Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">This Proxy Statement incorporates
by reference the Supplemental Materials, which were filed on Form&nbsp;DFAN on July&nbsp;19, 2024. Any statement contained in this Proxy
Statement or in a document incorporated or deemed to be incorporated by reference herein will be deemed to be modified or superseded
for purposes of this Proxy Statement to the extent that a statement contained herein or in any other subsequently filed document which
also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any statement so modified or superseded
will not be deemed, except as so modified or superseded, to constitute a part of this Proxy Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">We are unaware of any other
matters to be considered at the 2024 Annual Meeting. However, should other matters, which the Politan Parties are not aware of a reasonable
time before this solicitation, be brought before the 2024 Annual Meeting, the persons named as proxies on the enclosed <B>WHITE universal
proxy card or voting instruction form</B> will vote on such matters in their discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Some banks, brokers and other
nominee record holders may be participating in the practice of &ldquo;householding&rdquo; proxy statements and annual reports. This means
that only one copy of this Proxy Statement may have been sent to multiple Stockholders in your household. We will promptly deliver a
separate copy of the document to you if you contact our proxy solicitor, D.F. King, at the following address or phone number: 48 Wall
Street, New York, New York 10005 or call toll free at (888) 628-8208. If you want to receive separate copies of our proxy materials in
the future, or if you are receiving multiple copies and would like to receive only one copy for your household, you should contact your
bank, broker or other nominee record holder, or you may contact our proxy solicitor at the above address or phone number.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Please refer to the Company
Proxy Statement and annual report for certain information and disclosure required by applicable law. Schedule II of this Proxy Statement
contains information regarding persons who beneficially own more than 5% of the shares and the ownership of the shares by the directors
and management of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">This Proxy Statement is dated
August&nbsp;6, 2024. You should not assume that the information contained in this Proxy Statement is accurate as of any date other than
such date, and the mailing of this Proxy Statement to Stockholders shall not create any implication to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">You are advised to read this
Proxy Statement, the Supplemental Materials (which are hereby incorporated into this Proxy Statement by reference) and other relevant
documents when they become available because they will contain important information. You may obtain a free copy of this Proxy Statement,
the Supplemental Materials and other relevant documents that we file with the SEC at the SEC&rsquo;s website at www.sec.gov or by calling
or submitting a written request to D.F. King at the phone number and address indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>YOUR VOTE IS IMPORTANT,
NO MATTER HOW FEW SHARES OF COMMON STOCK YOU OWN. WE URGE YOU TO SIGN, DATE, AND RETURN THE ENCLOSED UPDATED WHITE PROXY CARD OR VOTING
INSTRUCTION FORM&nbsp;TODAY TO VOTE &ldquo;FOR&rdquo; WILLIAM JELLISON AND DARLENE SOLOMON TO BE ELECTED TO SERVE AS CLASS&nbsp;II MEMBERS
OF THE BOARD UNTIL THE 2025 ANNUAL MEETING OR UNTIL THEIR RESPECTIVE SUCCESSORS ARE DULY ELECTED AND QUALIFIED AND &ldquo;FOR&rdquo;
THE BYLAW PROPOSAL.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">WE HAVE OMITTED FROM THIS PROXY
STATEMENT CERTAIN DISCLOSURE REQUIRED BY APPLICABLE LAW THAT IS REQUIRED TO BE INCLUDED IN THE COMPANY PROXY STATEMENT RELATING TO THE
2024 ANNUAL MEETING BASED ON OUR RELIANCE ON RULE 14A-5(C)&nbsp;UNDER THE EXCHANGE ACT. THIS DISCLOSURE INCLUDES, AMONG OTHER THINGS,
CURRENT BIOGRAPHICAL INFORMATION ON THE COMPANY&rsquo;S DIRECTORS AND EXECUTIVE OFFICERS,&nbsp;INFORMATION CONCERNING EXECUTIVE COMPENSATION
AND DIRECTOR COMPENSATION,&nbsp;INFORMATION CONCERNING THE BOARD AND ITS COMMITTEES OF THE BOARD,&nbsp;INFORMATION CONCERNING CERTAIN
RELATIONSHIPS AND RELATED PARTY TRANSACTIONS,&nbsp;INFORMATION ABOUT THE COMPANY&rsquo;S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM,&nbsp;INFORMATION
ON HOW TO ATTEND THE 2024 ANNUAL MEETING AND VOTE IN PERSON,&nbsp;INFORMATION CONCERNING THE PROCEDURES FOR SUBMITTING STOCKHOLDER PROPOSALS
AND DIRECTOR NOMINATIONS INTENDED FOR CONSIDERATION AT THE 2025 ANNUAL MEETING AND FOR CONSIDERATION FOR INCLUSION IN THE COMPANY&rsquo;S
PROXY MATERIALS FOR THAT MEETING, AND OTHER IMPORTANT INFORMATION. WE TAKE NO RESPONSIBILITY FOR THE ACCURACY OR COMPLETENESS OF ANY
INFORMATION THAT WE EXPECT TO BE CONTAINED IN THE PRELIMINARY OR DEFINITIVE COMPANY PROXY STATEMENT. EXCEPT AS OTHERWISE NOTED HEREIN,
THE INFORMATION IN THIS PROXY STATEMENT CONCERNING THE COMPANY HAS BEEN TAKEN FROM OR IS BASED UPON DOCUMENTS AND RECORDS ON FILE WITH
THE SEC AND OTHER PUBLICLY AVAILABLE INFORMATION. <B>STOCKHOLDERS ARE DIRECTED TO REFER TO THE COMPANY PROXY STATEMENT FOR THE FOREGOING
INFORMATION. STOCKHOLDERS CAN ACCESS THE COMPANY PROXY STATEMENT AND ANY OTHER RELEVANT DOCUMENTS DISCLOSING THIS INFORMATION, WITHOUT
COST, ON THE SEC&rsquo;S WEBSITE AT WWW.SEC.GOV, OR BY WRITING TO THE COMPANY&rsquo;S CORPORATE SECRETARY, C/O MASIMO CORPORATION, 52
DISCOVERY,&nbsp;IRVINE, CALIFORNIA 92618.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; font: bold 10pt Times New Roman, Times, Serif">Politan Capital Management LP</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">August&nbsp;6, 2024</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Cautionary
Statement Regarding<BR>
Forward-Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The information herein contains
 &ldquo;forward-looking statements.&rdquo; Specific forward-looking statements can be identified by the fact that they do not relate strictly
to historical or current facts and include, without limitation, words such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;expects,&rdquo;
 &ldquo;believes,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;plans,&rdquo; &ldquo;estimates,&rdquo; &ldquo;projects,&rdquo; &ldquo;potential,&rdquo;
 &ldquo;targets,&rdquo; &ldquo;forecasts,&rdquo; &ldquo;seeks,&rdquo; &ldquo;could,&rdquo; &ldquo;should&rdquo; or the negative of such
terms or other variations on such terms or comparable terminology. Similarly, statements that describe our objectives, plans or goals
are forward-looking. Forward-looking statements are subject to various risks and uncertainties and assumptions. There can be no assurance
that any idea or assumption herein is, or will be proven, correct. If one or more of the risks or uncertainties materialize, or if Politan&rsquo;s
underlying assumptions prove to be incorrect, the actual results may vary materially from outcomes indicated by these statements. Accordingly,
forward-looking statements should not be regarded as a representation by Politan that the future plans, estimates or expectations contemplated
will ever be achieved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Certain statements and information
included herein have been sourced from third parties, including Glass Lewis and ISS. Politan does not make any representations regarding
the accuracy, completeness or timeliness of such third party statements or information. Except as may be expressly set forth herein,
permission to cite such statements or information has neither been sought nor obtained from such third parties. Any such statements or
information should not be viewed as an indication of support from such third parties for the views expressed herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Annex
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION CONCERNING PARTICIPANTS IN THE
SOLICITATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Politan Parties, William
Jellison and Darlene Solomon may be deemed &ldquo;participants&rdquo; under SEC rules&nbsp;in this solicitation. Information regarding
the participants in the solicitation is set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Except as described in the
Proxy Statement, no Participant in this solicitation beneficially owns any securities of the Company or has any personal ownership interest,
direct or indirect, in any securities of the Company. Set forth in this Annex A are transactions in the Company&rsquo;s securities effected
by the participants in this solicitation within the past two years. <FONT STYLE="background-color: white">The source of funding for these
transactions was derived from the respective capital of the Politan Funds. </FONT>The Politan Shares (other than the Common Stock held
by the Record Stockholder) which the applicable Politan Parties hold in &ldquo;street name&rdquo; may be held in brokerage custodian
accounts which, from time to time in the ordinary course, may utilize margin borrowing in connection with purchasing, borrowing or holding
of securities, and such shares of Common Stock may thereby have been, or in the future may become, subject to the terms and conditions
of such margin debt and terms, together with all other securities held therein. Except as described herein, as of the date hereof, no
part of the purchase price or market value of any securities of the Company described in <I>Annex A</I> are represented by funds that
were borrowed or otherwise obtained for the purpose of acquiring or holding such securities by any participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>PERSONS MAKING THE SOLICITATION AND OTHER PARTICIPANTS:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The name, principal business
address and the principal occupation or employment of the Politan Parties and the other participants in this solicitation is set forth
below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>POLITAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Politan is a Delaware limited
partnership whose principal business address is 106 West 56th Street, 10th Floor, New York, New York 10019. The principal business of
Politan is to serve as investment advisor to certain affiliated funds, including the Politan Funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>POLITAN MANAGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Politan Management is a Delaware
limited liability company whose principal business address is 106 West 56th Street, 10th Floor, New York, New York 10019. The principal
business of Politan Management is to serve as the general partner of Politan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>POLITAN GP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Politan GP is a Delaware limited
liability company whose principal business address is 106 West 56th Street, 10th Floor, New York, New York 10019. The principal business
of Politan GP is to serve as the general partner of certain affiliated funds, including the Politan Funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 49; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>QUENTIN KOFFEY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Quentin Koffey&rsquo;s principal
business address is 106 West 56th Street, 10th Floor, New York, New York 10019. Mr.&nbsp;Koffey is a United States citizen. The principal
occupation of Mr.&nbsp;Koffey is to serve as the Managing Partner and Chief Investment Officer of Politan and the Managing Member of
Politan Management and Politan GP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>RECORD STOCKHOLDER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Record Stockholder is a
New York limited liability company whose principal business address is 106 West 56th Street, 10th Floor, New York, New York 10019. The
principal business of the Record Stockholder is to invest in securities and serve as the record holder of shares of companies in which
the Politan Funds may invest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>POLITAN LTD.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Politan Ltd. is an exempted
company under the laws of the Cayman Islands, whose principal business address is 106 West 56th Street, 10th Floor, New York, New York
10019. The principal business of Politan Ltd. is to invest in securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>POLITAN MASTER FUND</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Politan Master Fund is an exempted
limited partnership organized under the laws of the Cayman Islands, whose principal business address is 106 West 56th Street, 10th Floor,
New York, New York 10019. The principal business of Politan Master Fund is to invest in securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>POLITAN LP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Politan LP is Delaware limited
partnership, whose principal business address is 106 West 56th Street, 10th Floor, New York, New York 10019. The principal business of
Politan LP is to invest in securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>POLITAN OFFSHORE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Politan Offshore is an exempted
company organized under the laws of the Cayman Islands, whose principal business address is 106 West 56th Street, 10th Floor, New York,
New York 10019. The principal business of Politan Offshore is to invest in securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>AARON KAPITO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Aaron Kapito&rsquo;s principal
business address is 106 West 56th Street, 10th Floor, New York, New York 10019. Mr.&nbsp;Kapito is a United States citizen. The principal
occupation of Mr.&nbsp;Kapito is to serve as an investment analyst of Politan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>MATTHEW HALL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Matthew Hall&rsquo;s principal
business address is 106 West 56th Street, 10th Floor, New York, New York 10019. Mr.&nbsp;Hall is a Canadian citizen and permanent United
States resident. The principal occupation of Mr.&nbsp;Hall is to serve as an investment analyst of Politan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>WILLIAM JELLISON</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">William Jellison&rsquo;s principal
business address is 9946 W. Gull Lake Dr., Richland, Michigan 49083. Mr.&nbsp;Jellison is a United States citizen. The principal occupation
of Mr.&nbsp;Jellison is serving on the Boards of Directors of Young Innovations,&nbsp;Inc., Avient Corporation (NYSE: AVNT) and Anika
Therapeutics,&nbsp;Inc. (NASDAQ: ANIK) and serving as an independent business consultant and M&amp;A Advisor for Astor Place Holdings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>DARLENE SOLOMON</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Darlene Solomon&rsquo;s principal
business address is 17 Valley Oak, Portola Valley, CA 94028. Dr.&nbsp;Solomon is a United States citizen. The principal occupation of
Dr.&nbsp;Solomon is serving on the Boards of Directors of Materion Corporation (NYSE: MTRN) and Novanta Inc (NASDAQ: NOVT).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>Schedule
I</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TRANSACTIONS IN SECURITIES OF THE COMPANY<BR>
DURING THE PAST TWO YEARS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>POLITAN CAPITAL PARTNERS MASTER FUND LP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Nature of Transaction</TD><TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Shares of Common Stock<BR> Purchased / (Sold)</TD><TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Date of <BR> Purchase / Sale</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">37,299</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 16%; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">5/17/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">42,639</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">5/18/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">62,294</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">5/19/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">62,750</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">5/20/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">60,097</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">5/23/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">31,133</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">5/24/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">123,195</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">5/25/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">54,943</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">5/26/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,200</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">5/27/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">31,590</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">5/31/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">100,000</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">6/1/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">39,474</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">6/2/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">70,995</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">6/3/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">32,037</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">6/6/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">44,458</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">6/7/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">48,901</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">6/8/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">50,604</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">6/9/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">97,566</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">6/10/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">258,720</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">6/13/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">79,180</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">6/14/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">8,198</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">6/16/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">34,495</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">6/23/22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">19,680</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">6/24/22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">30,883</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">6/27/22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">151,859</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">6/28/22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">148,160</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">6/29/22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">124,057</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">6/30/22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">22,000</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">7/1/22</TD></TR>
  </TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 52; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">I-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Nature of Transaction</TD><TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Shares of Common Stock<BR> Purchased / (Sold)</TD><TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Date of <BR> Purchase / Sale</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">22,000</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 16%; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">7/5/22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">21,800</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">7/6/22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">21,500</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">7/7/22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">20,000</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">7/8/22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">11,020</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">7/13/22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">236,651</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">7/18/22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">151,029</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">7/19/22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">107,389</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">7/20/22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">111,988</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">7/21/22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">100,000</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">7/22/22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">425,000</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">8/10/22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of Common Stock</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">107,000</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">8/10/22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">350,000</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">8/11/22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of Common Stock</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">100,000</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">8/11/22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">315,000</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">8/12/22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of Common Stock</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">52,500</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">8/12/22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">335,000</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">8/15/22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of Common Stock</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">75,000</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">8/15/22</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">197,585</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">8/16/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of Common Stock</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">20,000</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">8/23/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Sale of OTC Physically-Settled Total Return Swap</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(4,294,369</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">9/23/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of Common Stock</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,294,369</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">9/23/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of Common Stock</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,253</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">12/2/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of Common Stock</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">20,590</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">12/5/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of Common Stock</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">29,000</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">12/6/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of Common Stock</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">9,196</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">12/7/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of Common Stock</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">17,804</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">12/8/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of Common Stock</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">14,400</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">12/9/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Purchase of Common Stock</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7,195</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">12/12/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Sale of Common Stock</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(10,344</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">12/15/2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 3pt">Sale of Common Stock</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(26,445</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; padding-left: 3pt">4/12/2023</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The transactions with respect
to which Mr.&nbsp;Koffey may be deemed to be a beneficial owner by virtue of his position as the Managing Partner and Chief Investment
Officer of Politan and as the Managing Member of Politan Management and Politan GP have been set forth above. The transaction with respect
to which Mr.&nbsp;Koffey may be deemed to be a beneficial owner by virtue of his position as a director has been set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">I-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Quentin Koffey</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Nature
    of&nbsp;&nbsp;Transaction</TD><TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">RSUs
    Granted</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Date
    of Grant</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Vesting
    Date of <BR> RSUs into <BR> Common Stock</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 62%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant
    of RSUs to non-employee director<SUP>6</SUP></FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">1,228</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6/26/2023</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 10%; padding-bottom: 1pt">6/26/2024</TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Mr.&nbsp;Jellison and Dr.&nbsp;Solomon
have had no transactions with respect to the Company&rsquo;s securities during the past two years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>6</SUP></FONT></TD><TD STYLE="text-align: justify">Each
                                            year on the date of the Company&rsquo;s annual meeting of stockholders, each non-employee
                                            director is granted an award of RSUs with respect to shares of Common Stock having a grant
                                            date fair value of $200,000, rounded down to the nearest whole share, which will vest on
                                            the earlier of the first anniversary of the grant date or the date of the next annual meeting
                                            of Stockholders or upon any earlier change in control of the Company.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">I-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>Schedule
II</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITY OWNERSHIP OF CERTAIN<BR>
BENEFICIAL OWNERS AND MANAGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">The
following table is reprinted from the Company Proxy Statement<SUP>7</SUP> and contains information regarding </FONT>persons <FONT STYLE="background-color: white">who
beneficially own more than 5% of the shares of Common Stock and the ownership of the shares by the directors and executive officers of
the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.25in; padding-bottom: 1pt; text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">Beneficial Ownership
    of <BR>
    Common Stock</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 10pt; font-weight: bold">Name</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">Number of<BR> Shares</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"><B>Percent of<BR>
    Class<SUP>(1)</SUP></B></TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif">5% Stockholders:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; width: 74%">Joe Kiani(2)</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">4,937,217</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">9.1</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BlackRock,&nbsp;Inc.<SUP>(3)</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5,659,131</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">10.6</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Vanguard Group<SUP>(4)</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,781,318</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">9.0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Politan
    Capital Management, LP<SUP>(5)</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,713,518</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">8.9</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FMR,
    LLC<SUP>(6)</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">6,927,572</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">13.0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif; text-align: left">Named Executive Officers, Directors and Director Nominees:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joe
    Kiani<SUP>(2)</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,937,217</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">9.1</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Micah
    Young<SUP>(7)</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">52,482</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bilal
    Muhsin<SUP>(8)</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">177,150</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tao
    Levy<SUP>(9)</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">65,190</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tom
    McClenahan<SUP>(10)</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">112,819</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Michelle Brennan</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&ndash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&ndash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Robert Chapek</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&ndash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&ndash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quentin
    Koffey<SUP>(5)</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,713,518</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">8.9</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Craig
    Reynolds<SUP>(11)</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">17,406</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher
    Chavez<SUP>(12)</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&ndash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&ndash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Shares Beneficially Owned By Current Executive Officers and Directors (10 persons)<SUP>(13)</SUP></FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 0.25in; font-size: 10pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">10,078,843</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">18.5</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">%</TD></TR>
  </TABLE>


<!-- Field: Rule-Page --><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">*</TD><TD STYLE="text-align: justify">Less than one percent.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(1)</SUP></FONT></TD><TD STYLE="text-align: justify">For
                                            each person and group included in this table, percentage ownership is calculated by dividing
                                            the number of shares beneficially owned by such person or group by the sum of shares of Common
                                            Stock outstanding as of May&nbsp;25, 2024, plus the number of shares of Common Stock that
                                            such person or group had the right to acquire within 60 days after May&nbsp;25, 2024.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(2)</SUP></FONT></TD><TD STYLE="text-align: justify">Comprised
                                            of 366,055&nbsp;shares of Common Stock held directly, 51,735&nbsp;shares of Common Stock
                                            held by Mr.&nbsp;Kiani&rsquo;s spouse, 2,250,291&nbsp;shares of Common Stock held in one
                                            trust for which Mr.&nbsp;Kiani is the sole trustee, 1,271,350&nbsp;shares of Common Stock
                                            held in four trusts for which Mr.&nbsp;Kiani is not the trustee, options to purchase 987,420&nbsp;shares
                                            of Common Stock that were exercisable as of May&nbsp;25, 2024 or that have or will become
                                            exercisable within 60 days after May&nbsp;25, 2024, and 10,366 shares of Common Stock held
                                            for the Reporting Person&rsquo;s account under the Masimo Retirement Savings Plan. As of
                                            May&nbsp;25, 2024, an aggregate of 2,447,778 shares of Common Stock owned by a family trust
                                            and beneficially owned by Mr.&nbsp;Kiani were pledged as collateral for personal loans. See
                                            &ldquo;Executive Compensation - Compensation Discussion and Analysis - Other Compensation
                                            Policies and Practices - Hedging and Pledging Policies&rdquo; included in the Company Proxy
                                            Statement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>7</SUP></FONT></TD><TD STYLE="text-align: justify">The
                                            table included in the Company Proxy Statement sets forth information as of May 25, 2024,
                                            per the Company&rsquo;s disclosure therein. The above table does not include the 1,228 Koffey
                                            Shares, which bring the total of Mr. Koffey&rsquo;s shares from 4,713,518 (as disclosed in
                                            the Company Proxy Statement) to 4,714,746 (as of the filing of this Proxy Statement).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 55; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(3)</SUP></FONT></TD><TD STYLE="text-align: justify">BlackRock,&nbsp;Inc.
                                            (&ldquo;<U>BlackRock</U>&rdquo;) filed a Schedule 13G/A on January&nbsp;24, 2024, reporting
                                            that it had sole voting power with respect to 5,491,069 shares of Common Stock, sole dispositive
                                            power with respect to 5,659,131 shares of Common Stock , and beneficial ownership of an aggregate
                                            of 5,659,131 shares of Common Stock in its capacity as a parent holding company or control
                                            person in accordance with Rule&nbsp;13d-1(b)(1)(ii)(G)&nbsp;under the Exchange Act. BlackRock
                                            filed an additional Schedule 13G/A on June&nbsp;7, 2024, reporting that, as of May&nbsp;31,
                                            2024, it had sole voting power with respect to 8,311,206 shares of Common Stock, sole dispositive
                                            power with respect to 8,480,230 shares of Common Stock, and beneficial ownership of an aggregate
                                            of 8,480,230 shares of Common Stock in its capacity as a parent holding company or control
                                            person in accordance with Rule&nbsp;13d-1(b)(1)(ii)(G)&nbsp;under the Exchange Act. BlackRock&rsquo;s
                                            address is 50 Hudson Yards, New York, New York 10001.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(4)</SUP></FONT></TD><TD STYLE="text-align: justify">The
                                            Vanguard Group (&ldquo;<U>Vanguard</U>&rdquo;) filed a Schedule 13G/A on February&nbsp;13,
                                            2024, reporting that it had shared voting power with respect to 24,155 shares of Common Stock,
                                            sole dispositive power with respect to 4,675,240 shares of Common Stock , shared dispositive
                                            power with respect to 106,078 shares of Common Stock and beneficial ownership of an aggregate
                                            of 4,781,318 shares of Common Stock in its capacity as an investment adviser in accordance
                                            with Rule&nbsp;13d-1(b)(1)(ii)(E)&nbsp;under the Exchange Act. Vanguard&rsquo;s address is
                                            100 Vanguard Blvd., Malvern, PA 19355.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(5)</SUP></FONT></TD><TD STYLE="text-align: justify">Includes
                                            shares of our common stock held by Politan Capital Management LP (&ldquo;<U>Politan LP</U>&rdquo;),
                                            Politan Capital Management GP LLC (&ldquo;<U>Politan Management</U>&rdquo;); Politan Capital
                                            Partners GP LLC (&ldquo;<U>Politan GP</U>&rdquo;); and Quentin Koffey (together with Politan
                                            LP, Politan Management and Politan GP, &ldquo;<U>Politan</U>&rdquo;). Politan filed a Schedule
                                            13D/A on June&nbsp;3, 2024, reporting that it had shared voting and dispositive power with
                                            respect to 4,713,518 shares of Common Stock, and beneficial ownership of an aggregate of
                                            4,713,518 shares of Common Stock. Politan&rsquo;s address is 106 West 56th Street, 10th Floor,
                                            New York, New York 10019.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(6)</SUP></FONT></TD><TD STYLE="text-align: justify">FMR
                                            LLC (&ldquo;<U>FMR</U>&rdquo;) and Abigail P. Johnson filed a Schedule 13G/A on February&nbsp;9,
                                            2024, reporting that FMR and Ms.&nbsp;Johnson had sole dispositive power with respect to
                                            6,927,572 shares of Common Stock in its capacity as a parent holding company in accordance
                                            with Rule&nbsp;13d-1(b)(1)(ii)(G)&nbsp;under the Exchange Act. FMR&rsquo;s address is 245
                                            Summer Street, Boston, Massachusetts 02210.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(7)</SUP></FONT></TD><TD STYLE="text-align: justify">Comprised
                                            of 10,536&nbsp;shares of Common Stock held directly and options to purchase 41,946&nbsp;shares
                                            of Common Stock that are exercisable within 60 days after May&nbsp;25, 2024.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(8)</SUP></FONT></TD><TD STYLE="text-align: justify">Comprised
                                            of 17,270&nbsp;shares of Common Stock held directly and options to purchase 159,880&nbsp;shares
                                            of Common Stock that are exercisable within 60 days after May&nbsp;25, 2024.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(9)</SUP></FONT></TD><TD STYLE="text-align: justify">Comprised
                                            of 11,208&nbsp;shares of Common Stock held directly and options to purchase 53,982&nbsp;shares
                                            of Common Stock that are exercisable within 60 days after May&nbsp;25, 2024.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>IMPORTANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Your vote is important. No
matter how many shares of Common Stock you own, please give us your proxy <B>FOR</B> the election of the Politan Nominees and in accordance
with our recommendations on the other proposals on the agenda for the 2024 Annual Meeting by <B>SIGNING, DATING AND MAILING</B> the enclosed
<B>updated WHITE universal proxy card or voting instruction form TODAY </B>in the envelope provided (no postage is required if mailed
in the United States).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>If
any of your shares of Common Stock are held in the name of a broker, only it can vote such shares of Common Stock and only upon receipt
of your specific instructions. </B></FONT>Depending upon your broker, you may be able to vote either by toll-free telephone or by the
Internet. Please refer to the enclosed voting form for instructions on how to vote electronically. You may also vote by signing, dating
and returning the enclosed <B>updated WHITE voting instruction form</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">If you have any questions or
require any additional information concerning this Proxy Statement, please contact D.F. King using the contact information set forth
below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>If you have any questions, require assistance
in voting your<BR>
<B>updated WHITE universal proxy card or voting instruction form</B>,<BR>
or need additional copies of Politan&rsquo;s proxy materials,<BR>
please contact D.F. King using the contact information provided here:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>D.F.&nbsp;King&nbsp;&amp;
Co.,&nbsp;Inc.</B></FONT><B><BR>
48 Wall Street<BR>
New York, New York 10005<BR>
Stockholders call toll-free: (888) 628-8208<BR>
Banks and Brokers call: (212) 269-5550<BR>
By Email: MASI@dfking.com</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 57 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UPDATED WHITE UNIVERSAL PROXY CARD OR VOTING
INSTRUCTION FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Masimo
Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2024 ANNUAL MEETING OF <FONT STYLE="text-transform: uppercase">STOCKHOLDERS</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THIS PROXY IS SOLICITED ON BEHALF OF<BR>
POLITAN CAPITAL MANAGEMENT LP<BR>
<FONT STYLE="text-transform: uppercase">and the other participants in its PROXY solicitation</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE BOARD OF DIRECTORS OF MASIMO CORPORATION<BR>
IS NOT SOLICITING THIS PROXY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROXY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The undersigned appoints Edward
McCarthy, Richard Brand and Quentin Koffey, and each of them, as attorneys and agents with full power of substitution to vote all shares
of common stock (the &ldquo;<U>Common Stock</U>&rdquo;) of Masimo Corporation (the &ldquo;<U>Company</U>&rdquo; or &ldquo;<U>Masimo</U>&rdquo;)
which the undersigned would be entitled to vote if personally present at the 2024 annual meeting of stockholders of the Company scheduled
to be held at 2:00 p.m.&nbsp;Pacific Daylight Time on September&nbsp;19, 2024, at the Masimo Corporation Headquarters located at 52 Discovery,&nbsp;Irvine,
California 92618 (including any adjournments or postponements thereof and any meeting called in lieu thereof, the &ldquo;<U>2024 Annual
Meeting</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The undersigned hereby revokes
any other proxy or proxies heretofore given to vote or act with respect to the shares of Common Stock of the Company held by the undersigned,
and hereby ratifies and confirms all action the herein named attorneys and proxies, their substitutes, or any of them may lawfully take
by virtue hereof. If properly executed, this Proxy will be voted as directed on the reverse and in the discretion of the herein named
attorneys and proxies or their substitutes with respect to any other matters as may properly come before the 2024 Annual Meeting that
are unknown to Politan Capital Management LP (&ldquo;<U>Politan</U>&rdquo;) a reasonable time before this solicitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>T</B></FONT><B>HIS
PROXY WILL BE VOTED AS DIRECTED. IF NO DIRECTION IS INDICATED WITH RESPECT TO THE PROPOSALS ON THE REVERSE, THIS PROXY WILL BE VOTED
<FONT STYLE="text-transform: uppercase">&ldquo;for&rdquo; </FONT>THE TWO <FONT STYLE="text-transform: uppercase">Politan </FONT>NOMINEES
AND &ldquo;WITHHOLD&rdquo; ON THE TWO COMPANY NOMINEES, &ldquo;FOR&rdquo; PROPOSAL NO. 2, &ldquo;AGAINST&rdquo; PROPOSAL NO. 3 AND &ldquo;FOR&rdquo;
PROPOSAL NO. 4.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">This Proxy will be valid until
the completion of the 2024 Annual Meeting. This Proxy will only be valid in connection with Politan&rsquo;s solicitation of proxies for
the 2024 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 58 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>If you have previously voted on the WHITE
    universal proxy card or voting instruction form for the annual meeting previously scheduled for July&nbsp;25, 2024, your vote is
    no longer valid. To enable your votes to be validly counted for the 2024 Annual Meeting, you must resubmit your vote on the updated
    WHITE universal proxy card or voting instruction form attached to this Proxy Statement for the 2024 Annual Meeting now scheduled
    to be held on September&nbsp;19, 2024.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Important Notice Regarding the Availability
    of Proxy Materials for the 2024 Annual Meeting:</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>This Proxy Statement and our updated WHITE
    universal proxy card or voting instruction form are available at</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>www.AdvanceMasimo.com</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>IMPORTANT: PLEASE SIGN, DATE, AND MAIL
    THIS PROXY CARD PROMPTLY!</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONTINUED AND TO BE SIGNED ON REVERSE SIDE</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 59 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>UPDATED WHITE UNIVERSAL PROXY CARD</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT>
<B>Please mark vote as in this example</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>POLITAN STRONGLY RECOMMENDS THAT STOCKHOLDERS
VOTE &ldquo;FOR&rdquo; THE TWO POLITAN NOMINEES AND &ldquo;WITHHOLD&rdquo; ON THE TWO COMPANY NOMINEES LISTED BELOW IN PROPOSAL NO. 1.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>YOU MAY&nbsp;SUBMIT VOTES &ldquo;FOR&rdquo;
UP TO TWO NOMINEES IN TOTAL. YOU ARE PERMITTED TO VOTE FOR LESS THAN TWO NOMINEES<I>. </I>IMPORTANTLY,&nbsp;IF YOU MARK MORE THAN TWO
 &ldquo;FOR&rdquo; BOXES WITH RESPECT TO THE ELECTION OF DIRECTORS, ALL OF YOUR VOTES FOR THE ELECTION OF DIRECTORS WILL BE DEEMED INVALID.
IF YOU MARK FEWER THAN TWO &ldquo;FOR&rdquo; BOXES WITH RESPECT TO THE ELECTION OF DIRECTORS, THIS PROXY CARD, WHEN DULY EXECUTED, WILL
BE VOTED ONLY &ldquo;FOR&rdquo; THOSE NOMINEES YOU HAVE SO MARKED.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">Election of two nominees to serve as directors
                                            until the Company&rsquo;s 2025 annual meeting of stockholders and until their successors
                                            have been duly elected and qualified.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5pt; width: 54%; border: Black 1pt solid; padding-left: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>POLITAN
    NOMINEES</B></FONT></TD>
    <TD STYLE="padding-right: 5pt; width: 23%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-left: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR</B></FONT></TD>
    <TD STYLE="padding-right: 5pt; width: 23%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-left: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WITHHOLD</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5pt; padding-left: 0.375in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)&nbsp;William
    Jellison</FONT></TD>
    <TD STYLE="padding-right: 5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-left: 5pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="padding-right: 5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-left: 5pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5pt; padding-left: 0.375in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)&nbsp;Darlene
    Solomon</FONT></TD>
    <TD STYLE="padding-right: 5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-left: 5pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="padding-right: 5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-left: 5pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5pt; border: Black 1pt solid; padding-left: 5pt; width: 54%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPANY
    NOMINEES OPPOSED BY POLITAN</B></FONT></TD>
    <TD STYLE="padding-right: 5pt; padding-left: 5pt; width: 23%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR</B></FONT></TD>
    <TD STYLE="padding-right: 5pt; padding-left: 5pt; width: 23%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WITHHOLD</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5pt; padding-left: 0.375in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
    Christopher G. Chavez</FONT></TD>
    <TD STYLE="padding-right: 5pt; padding-left: 5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="padding-right: 5pt; padding-left: 5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5pt; padding-left: 0.375in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
    Joe Kiani</FONT></TD>
    <TD STYLE="padding-right: 5pt; padding-left: 5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="padding-right: 5pt; padding-left: 5pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>POLITAN RECOMMENDS A VOTE &ldquo;FOR&rdquo;
PROPOSAL NO. 2.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">To ratify the selection of Grant Thornton
                                            LLP as the Company&rsquo;s independent registered public accounting firm for the fiscal year
                                            ending December&nbsp;28, 2024.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center; width: 33%"><FONT STYLE="font-family: Wingdings">&#168;</FONT> FOR</TD>
  <TD STYLE="text-align: center; width: 34%"><FONT STYLE="font-family: Wingdings">&#168;</FONT> AGAINST</TD>
  <TD STYLE="text-align: center; width: 33%"><FONT STYLE="font-family: Wingdings">&#168;</FONT> ABSTAIN</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>POLITAN RECOMMENDS A VOTE &ldquo;AGAINST&rdquo;
PROPOSAL NO. 3.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">An advisory
                                            vote to approve the compensation of the Company&rsquo;s named executive officers.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center; width: 33%"><FONT STYLE="font-family: Wingdings">&#168;</FONT> FOR</TD>
  <TD STYLE="text-align: center; width: 34%"><FONT STYLE="font-family: Wingdings">&#168;</FONT> AGAINST</TD>
  <TD STYLE="text-align: center; width: 33%"><FONT STYLE="font-family: Wingdings">&#168;</FONT> ABSTAIN</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>POLITAN RECOMMENDS A VOTE &ldquo;FOR&rdquo;
PROPOSAL NO. 4.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">4.</TD><TD STYLE="text-align: justify">The Politan Parties&rsquo; proposal to repeal
                                            any provision of, or amendment to, the Bylaws, adopted by the Board without Stockholder approval
                                            subsequent to April&nbsp;20, 2023 and up to and including the date of the 2024 Annual Meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center; width: 33%"><FONT STYLE="font-family: Wingdings">&#168;</FONT> FOR</TD>
  <TD STYLE="text-align: center; width: 34%"><FONT STYLE="font-family: Wingdings">&#168;</FONT> AGAINST</TD>
  <TD STYLE="text-align: center; width: 33%"><FONT STYLE="font-family: Wingdings">&#168;</FONT> ABSTAIN</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NOTE: In their discretion, the proxies are authorized
to vote upon such other business as may properly come before the meeting or any adjournment or postponement thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Proxy is governed by the laws of the State
of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 60 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">DATED:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%; border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(Signature)</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(Signature, if held
    jointly)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(Title)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">WHEN SHARES ARE HELD JOINTLY, JOINT OWNERS SHOULD
EACH SIGN. EXECUTORS, ADMINISTRATORS, TRUSTEES,&nbsp;ETC., SHOULD INDICATE THE CAPACITY IN WHICH THEY ARE SIGNING. PLEASE SIGN EXACTLY
AS NAME APPEARS ON THIS PROXY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UPDATED WHITE UNIVERSAL PROXY CARD</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 61; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
